var title_f3_31_3568="Subacute HP CT";
var content_f3_31_3568=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F71870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F71870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Subacute hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 363px; height: 213px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Subacute hypersensitivity pneumonitis (extrinsic allergic alveolitis) with multiple so-called acinar nodules permeating the entire lung.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3568=[""].join("\n");
var outline_f3_31_3568=null;
var title_f3_31_3569="Reciprocal translocation CML";
var content_f3_31_3569=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F72417&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F72417&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Reciprocal translocation in CML",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 408px; height: 460px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHMAZgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKzfEWrx6HpbXsltcXX76GBIbfZvkeWVYkA3sq/ecckgYoA0qK5r/AISPVP8AoS/EH/f6w/8Akmj/AISPVP8AoS/EH/f6w/8AkmgDpaK5r/hI9U/6EvxB/wB/rD/5Jo/4SPVP+hL8Qf8Af6w/+SaAOlormv8AhI9U/wChL8Qf9/rD/wCSaP8AhI9U/wChL8Qf9/rD/wCSaAOlormv+Ej1T/oS/EH/AH+sP/kmj/hI9U/6EvxB/wB/rD/5JoA6Wiua/wCEj1T/AKEvxB/3+sP/AJJo/wCEj1T/AKEvxB/3+sP/AJJoA6Wiua/4SPVP+hL8Qf8Af6w/+SaP+Ej1T/oS/EH/AH+sP/kmgDpaK5r/AISPVP8AoS/EH/f6w/8Akmj/AISPVP8AoS/EH/f6w/8AkmgDpaK5r/hI9U/6EvxB/wB/rD/5Jo/4SPVP+hL8Qf8Af6w/+SaAOlormv8AhI9U/wChL8Qf9/rD/wCSaP8AhI9U/wChL8Qf9/rD/wCSaAOlormv+Ej1T/oS/EH/AH+sP/kmj/hI9U/6EvxB/wB/rD/5JoA6Wiua/wCEj1T/AKEvxB/3+sP/AJJrX0LU4da0TT9UtVkS3vreO5jWQAMFdQwBAJGcHsTQBeooooAKKKKACiiigArw3S/EPgyXU/Ei+LvGN1aahDrN3AsP/CR3dtsjWTCgRpKqgDkDAHSvcq+Mdb+Afivxt4y8W6zpd3o8FrJrd6qrdTSq5/fMc4WNhj5vXsaAPbf7c+FX/Q9Xf/hW3/8A8fo/tz4Vf9D1d/8AhW3/AP8AH68K/wCGVfHH/QT8Of8AgTN/8Zo/4ZV8cf8AQT8Of+BM3/xmgD13xj4i+Hdv4T1ibQ/HF42qR2sjWwXxVfOTJtO3C+fyc445r3Oycy2dvIzbmeNWJ9civiHXv2afGmi6LfancX2hTQ2cLTukM8zOyqMnAMQGce4r7b00Y061B7RJ/IUAWaKKKACiiigAooooA8t+I2p6XZ/ETRofFOu3Ok6G+k3Ug2arNYJJcLNbheY3QswVn454yccVQ/tz4Vf9D1d/+Fbf/wDx+uc/aU8Bap8SPGXhnRdCnsoLu3sLu8drx2RCgkgTAKqxzlh26Z5ry3/hlXxx/wBBPw5/4Ezf/GaAPdf7c+FX/Q9Xf/hW3/8A8fo/tz4Vf9D1d/8AhW3/AP8AH68K/wCGVfHH/QT8Of8AgTN/8Zo/4ZW8cf8AQT8Of+BM3/xqgD6V+Dmo2mpWPiU6Xqk2p6dBrMsNtPJey3eEEMJAEkjMSMkng45OK9Brx39mDwvf+DfB+v6LqrQvdW+tyhnhLFG/cwcqWAJHHpXsVABRRRQAUUUUAFc18Qv+QDa/9hbTP/S+CulrmviF/wAgG1/7C2mf+l8FAHS02SRIgDI6oGYKCxxkngD606vLf2kk1SX4XXkOhLKb6SaNfMRtgijOfMdn4VECbtzsQqgkkigD0/zo8geYmSCwG4cgYyfpyPzFKZEH8a/n/n0NfneLTPhybTfDN/JJYoIJdf1l3kitAHdRDEFI3lUJY42l3beVTEYJh1S50m/jtdL0e6Nj4d0+Um61Sc5u7+Uo7eZ5O7JGI3WNB8qGTDuplZiAfoqZow6IZEDvkKNwy2OuPWn18N/BSWDUfi14Tu7aS20rS7eeSKxsRMbi4nbbiRpNvSRgwZpHCKQuEBCBB9yUAFFFQJeW0ly9tHcQtcIMtEHBZR7jqKAJ6KKKACiiigAooooAKKKKACiiigAooooAK5r4Zf8AJNvCf/YJtP8A0SldLXNfDL/km3hP/sE2n/olKAOlooooAKKKKACiiigAr82/ipcTR/FHxksc0iL/AG1enCsQM+e9fpJX5rfFj/kqfjL/ALDV7/6PegDm/tdz/wA/E3/fZo+13P8Az8Tf99moKKAJnuZ3Qo80rKeoLkg1+oumEnTbQn/nin8hX5aV+pel/wDIMtP+uKf+gigCzRRRQAUUUUAFFFFAHyj+29NJDqPhExSPGWhugSrEZG6I4/QV8wfa7n/n4m/77NfTf7cn/IQ8H/8AXK6/nFXy7QBP9ruf+fib/vs0fa7n/n4m/wC+zUFFAH2t+xazP8L9WZ2LM2tTEknJJ8iDmvfq8A/Yp/5JZqv/AGGpf/REFe/0AFFFFABRRRQAVzXxC/5ANr/2FtM/9L4K6Wua+IX/ACAbX/sLaZ/6XwUAdLXkv7UFkdR+E93a/abG0je5haS4vHCJEituLZwWJ44VAXboAc4r1qvIv2qY45fg3qYmuzbRCeFmwCfMw4ITAPc468ZAJ6ZAB8g6gdA1HSoLPSTBp2iaZ5cl1f3kMZ1LUJpCA+yMMTtUBtsYcRgLl3DOM0bm5tb+CzuL6K5sfC9rO8NpY2+WklbZukIlK7GlJEIkkPIEkZWMoixrs6ndadd6XZz3EN7YeC7W6ePT9NiZRPfMEJkleTp5pPkhpCpCh8IMRhDFNKlhNp+veLdPtp4pbVzpGhRSbI4VVkMRmjzvS3bzJHHO+UqWY/vDIQDsPgtm5+LHhC/1Yy21xMcaTplvbvFDDbgsM7nBHl4MxBXzGd1cuysxkP3LXxH8IZXtvjZo83iplvfFt9cIcSODHYLskV45EUjbMFVESMfLEGwV3KEX7coAgvkmksrhLWQR3DRssbnorY4P514d4H0+bS/DJtLPwZqFt4/tba7P9q3FkNj3BR8N9oJxJuJAAyRk88DNe8UUAfP1hceOx4d1ARXXiU3UjWQ2y2UvmwP5qiYozrhgVJJChlGM9KPFGi+JDcGC6n8UX2m6T4mtpoJ1iaWf7O0JLyJhMvsc4BUHG48V9A0UAeOyw+NpNB8b6hZXuuDUIL+a30yzljRVa2zETJGGTczbfMCndjI4GarNL4vfRNQTS5fEi6e+s2cVjNdQt9uW3YKLhmDLuCBs4LDp7V7XRQB4hocPjey16yIvPEF1DHq+oWAS+QmFrVUYwSyHYCctjEhODwBxxWBDd/EaLw/rMpm8Rtq5sDvtmsZW23AmT5on27PulxtjyNvOBjNfR1FAHi3xGtPGOnapZWem6t4gn0r7JI630EJmlF2ZCf3iwICVC7QoKheufWvXdGe4k0ixe9z9qaBDNlNh3lRu+XtznjtVyigAooooAKKKKACua+GX/JNvCf8A2CbT/wBEpXS1zXwy/wCSbeE/+wTaf+iUoA6WiiigAooooAKKKKACuF+F0UUkPinfHG2PEN9/CP74/Wu6r5y0n47eFfBGseLNH1i31Z7tNfvmJt4EZcebjqXHoe1AH0R9mg/54xf98Cj7NB/zxi/74FeGf8NSeBP+fTXv/AaP/wCOUf8ADUngT/n017/wGj/+OUAej/FiGFPhl4oKxRD/AIl838A/umup0/8A48Lb/rkv8hXzj47/AGj/AAZrngzW9LsrTWxdXdrJBF5lvGq7mGASfMOBX0dpxB0+1I6GJfbsKALFFFFABRRRQAUUUUAcNfqr/GzSVdQy/wDCPXvBGR/x82tdp9mg/wCeMX/fArz/AMSatp2i/GPRrrWL+0sLZ9BvI1mupliQt9otTtBYgZwCce1b3/CwfBv/AENvh/n/AKiMP/xVAHRfZoP+eMX/AHwKPs0H/PGL/vgVzv8AwsHwb/0Nnh//AMGMP/xVL/wsDwaf+Zs8P9M/8hGH/wCKoAofDUAXnjQBdv8AxUE/bH/LGGu1rgfhLfWeot4xudOuoLu2fxBPtlgkDo37mHoRwfwrvqACiiigAooooAK5r4hf8gG1/wCwtpn/AKXwV0tc18Qv+QDa/wDYW0z/ANL4KAOlqvf2NpqFv5F/awXUG4N5c8Ydcg5BweMg1YooAy5fDuizLGsuj6c6xp5aBrVCEXOdo44GecUp0DRzc/aG0qwNxuVvNNuhfKgBTnGeAAB6AADpWnRQBn22i6Va3ZurbTbKK6LM5mSBVcsxJZtwGckk5PfJzWhRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc18Mv8Akm3hP/sE2n/olK6Wua+GX/JNvCf/AGCbT/0SlAHS0UUUAFFFFABRRRQAV8qfFv8AZ2vpta8S+KNGuZtUS68++XTYtsc5uJHztViCrIu5nx95guwctuH1XRQB+Z2o6Ppul+F7W4utQW4169YSRWdrIrpawDcCZ2GcSMcYjByoBLYyoMmoeHIEu9P0fSbj+0ddO9r1oZU+yw4UNtWTOCI1DtJKSIxzg7ULt6H8SLywj+IfiO08DCG81/VbucTX1uVSGzt8HekT4VVJUO00xwFXcN23zGbgHaEW02i6BN/oHyHVdXaKTbKvmIoZgFLpbK7Jhdu522sw3eXHGAdr8OfgtefEDUom0WeSPw7bAR3msXClUuZQ3z/ZoyAxGCAN+Pulm2FhGPvC3iEFvFEpJEaBAT1OBiuP+DE+jz/Cvww3hty+mJZpEjtbiBmdMrIWQZAYyK5bBIJyQWzk9pQAUUUUAFFFFABRRRQB8u/to6Re6lfeEWtbeZ4wJ4d6wu6mR2iCJlVPzNzgd8Gvmi48OXlvfNZyvAbpY2maKImZ0RVLMXCBihVVYsrYZNp3AYNfptLEkyFJUV1PYivj/wDaU8CDwnq0MXgyytrLTPEO6S9WPEQi2SQptaQkJFbb5YmwSq72+Y4WMIAeEW/h27ub64s7ea0kuLdtsxWYGKP5xHlpv9UE3sq7y2wlhg8ii18OXl3p1xqFvJbmwtztkuZHMUYbGdoZwAz45Ea5cgEhSAcaYjbUUi0fT3trTw9azr9rv2kdYJ5gjnzpJGQNkqkvlR7NwXKqjSNIX+pf2aPDem6/4fj8T3VmscFtK9po1lv3LYRqwLyBhgtPIwG+QgEhcAKmFABo/sf6Ve6V8LrsX1vLCLnU3uYDJGyebE0EO11DAEqcHB6HtXuNQWVnbWFstvY28NtbqWKxQoEUEkkkAcckkn3JqegAooooAKKKKACua+IX/IBtf+wtpn/pfBXS1zXxC/5ANr/2FtM/9L4KAOlooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5r4Zf8AJNvCf/YJtP8A0SldLXNfDL/km3hP/sE2n/olKAOlooooAKKKKACiiigAr5N8f/E7xVres+L9HXU7HTtKguZ9JCQF0aJI7qKPzppAD5QcS43k7SEdAoYqa+sq+BPFd9ZW3xF8YvdPtNrr99NIRb20mEa5jA3RSsDdjKt+5+UIfnyQWAAMWKGOy8FXLWv2aK1uxvuZFlbfOF8tltvO27cqWDmEAElN7MQsYGwvhu1vbaw0CDVLC2sy0kkkiNLsuZUN4v2gv5f72AC2I84YjhWYZXPnM2Bc32mt4RV45CZTbCzybazUeaNjFRbhvMB4P+mZ3MPk2Dk1Ys9UsBrENwznyZJnvFPlWYHlK12TiItthXDLmyJIm5Acbo6AOx0bxX4i8KwtqHhTUYtJtLGwhnbTRA4t5QY7dj50ZXh38zCzsQZSjBGVTGtfbtnKZ7SCVgAZEViB2yM1+ettc6ZH4c1SO4lkW4hsAEG6wufmkjhCgsxDzA4bAQB7XA++d9foPpf/ACDLT/rin/oIoAs0UUUAFFFFABRRRQByfj34gaD4HhgGtTym9ulY2dlbxNJNdMCo2IAMbiWUDJHX618k/HfxbqPxH8TW/kread4eREa3tp7N1lcIH8+Zwm7f5JE4JzhAGAAJcn0/9q6a0i8VeD0vmKpPbXcKgRwEszNCAPNmIS3/AOu/Jj+9g4rwfxFcacbWKCzkk85rV1I+02CkGKO4VgJoySo5XII3XeSw2FkFAEd9Y2uo69a2F5PdWfhfTizRwQWhM0dsfL23Ei5277jfCPNLbSWUAhFjFetfCP4seIPDeranF4ksJ7nRpHKLpunWMqtpsyZBt4kICqERGZ4yc4XfknfnyO51Owl1uWZJNsSypdFjFZECJzabcx7tkyfK2LLIEGBl2CyVsWMmjzC7WZ5twS4sgRf6WhMgEjhS7H5z0zfjlxmJUyymgD7a8E+L9E8baO+qeGr37ZZJM0DP5bIVdQCQQwB6Mp+hFb9eH/skXEN34G8RXFqwaCXX53Qi1S1GDDB/yyQlU/3QSBXuFABRRRQAUUUUAFc18Qv+QDa/9hbTP/S+CulrmviF/wAgG1/7C2mf+l8FAHS0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc18Mv8Akm3hP/sE2n/olK6Wua+GX/JNvCf/AGCbT/0SlAHS0UUUAFFFFABRRRQAV8Ja4t0PiT4jeCHU3nPiXUl08Wt9LBLJP58O9bQopWKYIRveQMrIVAAZQT921836XYfCCbV/GLeNJNEXVpdevVlFzcskm0SgjjIxyOo68jPUUAeB30t3J4SUmHV/taaUiOZNSnaZbPdGFY/IIvsRc4WEfOHOS5UAVbsbe7bxKVNvqX2samEuUOozidb/AH3nkxyyBfmvCQPLmQCNSMup3SV9BHSf2efKMZl8N7Q2/i9fOcY678446dKeNO/Z+UKBceG/kjeFf9NbhW3bh97k/O3PUcYIwMAHzvpskkXhK9NlHetbvps0cL2l/dxRM3l25ufKQoVG3jzxIdkg4j2YSvvvTP8AkG2n/XFP/QRXzj47sPgWvg/XpNIl8PHU/sZEHlXTs+9VATYASc5A6DnnOcmvo/TgBp9qBjAiXp9BQBYooooAKKKKACiiigD50/ajklj8UeGNkd48DaffLciC5kgjEOYd5n8tS7wY++i4Zh0IOK8I8TEPpeZo5UsVtIlYyXl7JbqTDctahkdQTuXBtwp2xrgS7yXNfSvxp8DN8QviV4W0yLVDpc1jp91qMdwLcT/Ms1uoG0kD+LP4dK54/s2X5milPjo+ZHDcW6kaPHwk4cSj7/OfNk56jIxjAwAeISw3MXitAbXUmuv7TZLeP+0bjznvt1n58cUm3K3gyfNmYGN8nYq7Y6u280McN0WixCdPnSJ5NQ1LyzY7pArKqrn7DvwFhb955m1nfZuFevyfsz3krXLSeOSxubSCxmzpEfzQw+V5a/f4x5EfI5O3knJzOP2cdSFxcTjx2fNuLmS7lP8AY0WGlkRldsb+Mh24HAzkAECgDov2WPtQ8J+KRqEd/FeDxFcCVNQn8+4VxDACJJNq7mz1OBmvaK8n/Zz8K/8ACF+HfEmh/amuxba5MomMXl7h5MHOMn09a9YoAKKKKACiiigArmviF/yAbX/sLaZ/6XwV0tc18Qv+QDa/9hbTP/S+CgDpaKK5D4s+KrjwV4Ev9ftIreWS1kgBS4LBCrzJGxJXJGAxPAP0PSgDr6K+a7j4/eJra1lurnQNKhtEZiLiT7YsbxFGaGYMYceXMUZYycFiDkKASM//AIaS8R/avsX/AAjemf2ptx/Z3mXH2nz/AD/J+z7PL/1v8e3pt77vloA+pKK8E+Ffxxv/ABr44sNDltNHSKdC7m1kmeQDyDLn5kVQFYCNuc7j8oIy1e90AFFMmkSGJ5ZWCRopZmPQAdTXF+GfH39vbL2PQtRtfDsqyPFq9w8SxFUBJdl3bkU7ThiPTpQB29Fcvb+P/C0+m3N+mtWotLYoJpHymzecISGAOG7HofWki+IHhWXS31GLWrdrVLj7KSA24y4zsCY3E45wB0BNAHU0VxB+Jvhx9bi0q3uWkuJrJr2KQrsiYBiuwk/MG4J5XAAPOeKSw+JmhT6rp+mXUvkXl5p41EOrCSEKT9wOMEnGT93GB17UAdxRXK674/8ADujaIdTnvlmhNmb+JIBl5ochdyA4ByWUckdar23xD0SdhObqCPS/7OXUTcvJhlUymIgx44AYY3Zxnj3oA7KisG/8X6BYfbPteqW6G0kjhmGSxEki7kQADLMRyAMmtDRdWsNc02LUNJuo7qzlzsljPBIOCPUEEEEGgC9RRRQAUUUUAFc18Mv+SbeE/wDsE2n/AKJSulrmvhl/yTbwn/2CbT/0SlAHS0UUUAFFFFABRRRQAV+a3xY/5Kn4y/7DV7/6Pev0pr5jtvh58Ldf17xZfeLNZgtdUbXr4Oj6tHCQPM/unGOSfxzz0AAPkeivsT/hUXwO/wChktP/AAeRf40f8Ki+B3/QyWn/AIPIv8aAPjuv1L0v/kGWn/XFP/QRXzB4x+F/wb07wlrF5pev28t/BavJbqmtROS4HygAZzzgYxX1BpwA0+1A6eUv8hQBYooooAKKKKACiiigD5Y/bS1G+0zVvCcum3lzZyvBdRu9vK0bMu6E7SQRkZAOPUCvmz/hK/EPH/E+1b/wMk/xr7A/aB+H03xM8ceHNEtb+OwmttNu73zZIy6sBLbptwCMffznnpXnv/DJmr/9DRYf+Az/AONAHgP/AAlXiH/oPat6f8fkn+NB8VeISMHXtW6Y/wCPyTp+de/f8Mmav/0NFh/4DP8A40f8Mmav/wBDRYf+Az/40AehfsaXM958NdZuLuaWeeTW5WeWVyzMfIg5JPJNe9V5F+zX4Wm8GeGPEeh3FzHdPa67MvnIhUMPJg5wen6/U167QAUUUUAFFFFABXNfEL/kA2v/AGFtM/8AS+CulrmviF/yAbX/ALC2mf8ApfBQB0teWftPCNvgj4gFw7pCXtQ7IoZlX7VFkgEjJx2yPqK9Tryz9p8ovwQ8QtKheMPallDbSw+1RZGecfWgD451Gw0NNFlcx2MOEi2TWzpLO0W2Ty5TH9ubE0jACWLYREApGCcNim3sh4j2bLYXHnf8eQkX7F5vn48n7R9oz5Hl8+dvznjOP3ldXqz2S+G555dMuDaeXAyxiyEO2KRJhbqZ/IGTGwLGTI88cfwZFAC0/wCFkDTzbyjUv7Q+y/bvsZ/4+ftuftH2Hy+nl/J9m29ff5aAO0/ZWj09PjDpjWd1dSz+TKCktssahDbkudwdjkSYUDHzL8xKn5K+46+Hf2Wp7Cb4x6WLGymtpRbvuZrjzAwFsVk42jlpPnBz8o+XB+9X3FQBHcQx3NvLBOoeKVSjqe6kYIrzvSvhvqFnoU/hy48UTXHhhrea2js/saJMiSKwAM2Tu27sj5R0GeOK7/UuNOuiOvlP/I18/eD/ABT4r8OeFNAS0ni1eK80C5u7azNth4pISMfMGLSZ3cjjOOMUAdzL8Kpru1uP7S18T30i2UCTpZCNEhtpA6rsD8sx6tn6DtU/iD4X/wBrXOtTDUrZTqN/HfBZ7IyCIpF5eAVkRge+5WX05rzvUPGvifVPBGq3C+IrfZaXFhN9qswBLEjybZEl8vAVQcHB5wCD1zW5qfxB8R2/jGKxh1LTRZR/YzAZ41jXVIpEUvKh5JJLHATO3GDmgZ1Vl8Nbqxn02aHxHPNLb6TLpFzJd2/nNPG778g7wVIOAM7vlAHvT9O+G0mn3GiSQaz8tlox0S5U2uftEJIYsp3/ALtsj/arn28YeLP+EU1vXBe2ht4NUk05VWxLG1jW4CNcMd3z7UzxtHqc4quvj/XW061EuqQQaRJrE9kfExtAYzbpGGR9v3Ms5Kb/ALvy0Aadn8IroWgtdR8TNdQRaPPo0AWxWMxxuRtYkOdxGO/X2ratPh20l1JNreqJfibQf7ClSO08kMnmMwkHztg7WAx6jOecDzfU9f1201Xxbr+heIbec2Ok2Vy0rWWUvBuccKW+QEZyRnPGCBXUSeMPFsuneN9V097WeLRZXht7BbQs7kxowYuG6LuJxtycdaALcHwfiTwda6VLrUk2qQah/aJ1F7fiSQLsCtHu5UJhcBgeMgiu38E+Hv8AhGdE+wGW3lYyvMzW9v5CEscnClmP4liTXmD+Ptfj8O+IJ9O1S11SG0vbC3stY+yBY5vOZRKm0EA7CQOMfeweRS6P4y8VweILWHUdUtr2zi8RT6FLGliEeZVi8wSZDHBGQAoHbnOaAPbKK+dLL4h+Jdfi8Q2VpqpdJdCvLu3KQql1byxnAXEfKMQSACWYZBz627Hxjf21smoW2o2uqXkHguW9W+MWW81ZkGxjk52ng55JBJoEfQFFec/D/XteuPF97pOu39vfxNpdtqUTx2wg8oyEgpgE5HHUnNejUAFc18Mv+SbeE/8AsE2n/olK6Wua+GX/ACTbwn/2CbT/ANEpQB0tFFFABRRRQAUUUUAFfmt8WP8AkqfjL/sNXv8A6Pev0pr5v074DeFfHWteK9Z1S+1uC6fXb2Nltp4gnEpOQGiJH3vXtQB8d0V9q/8ADKngf/oK+JP/AAIg/wDjNH/DKngf/oK+JP8AwIg/+M0AfFVfqXpf/IMtP+uKf+givm/xr+zX4M0DwjrGrW+oeIZZrK1knRJLmHaWVSRnEPTNfSOnADT7UDoIl/kKALFFFFABRRRQAUUUUAfL37Y+t6r4f1zwnd6FqN5pt1JbXULzWkzROyb4TtLKQcZAOPavnn/hZXjn/ocfEX/gym/+Kr6k/aR8A6n8SfGfhrRdEuLO3urfT7u8Z7tmVCgkgTAKqxzlh2ry/wD4ZU8bf9Bbw5/3/n/+NUAeV/8ACyvHP/Q4+Iv/AAZTf/FUf8LL8c/9Dj4i/wDBlN/8VXqn/DKnjb/oLeHP+/8AP/8AGqP+GVPG3/QW8Of9/wCf/wCNUAevfseahe6p8OdZvNTu7i8u5dblLzTyGR2PkQdSeTXutePfsxeGLvwd4R8QaJqE9tPdW2tyq725YpnyIOm5Qf0r2GgAooooAKKKKACua+IX/IBtf+wtpn/pfBXS1zXxC/5ANr/2FtM/9L4KAOlrB8deF7Pxn4ZutD1OWeK0uGjZ2g2bvkkVwPnVlIyoyCDxW9RQB4037Pfhp1kWTVNXeOR5JCjRWZUF0KYA+z4CqCSij5UY5UA1B/wzj4W3iQatrouPL2fad1v5+fO87zPM8nd5u/jzM7tvy5xXtlFAHl/gn4K+H/B/iS11nS73UGuLcACN47ZVbEJhG4pCrfdO4jdhnwxyea9QooGe9ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzXwy/5Jt4T/AOwTaf8AolK6Wua+GX/JNvCf/YJtP/RKUAdLRRRQAUUUUAFFFFABXzhpnx48LeB9b8WaNq9nrMt0mvXrlreGNkx5pHUyA9j2r6Pr5psfgJ4e8d634t1nUdT1a3uX16+TZA0YQASZ6FCepPf0oA2f+GqPA3/QO8Rf+A0P/wAdo/4ap8Df9A3xH/4DQ/8Ax2qv/DKXhH/oN69/33D/APG6P+GUvCP/AEG9e/77h/8AjdAGb45/aT8Ha74N1rSrPT9eW5vLSSCMywRKoZgQCSJDgfga+kdOIOn2pHQxLjjHYV8zeNf2afC2geEdZ1a31fW5JrK1knjV2iKkqM4OEzj8q+mdNGNOtQM4ESdfoKALFFFFABRRRQAUUUUAec+JtY0zQ/jFo13reo2enWraDeRrNdzrChf7RanaGYgZwCce1bv/AAsXwT/0OHhz/wAGcH/xVePftPeB9X+IPizwzpPh4W7XtvY3d26zybAUEkCcHHXLD9a8g/4Zo+If/Pvpn/gYP8KAPsD/AIWL4J/6HDw5/wCDOD/4qj/hYvgn/ocPDn/gzg/+Kr4//wCGaPiH/wA++mf+Bg/wo/4Zo+If/Pvpn/gYP8KAPq34T3lpqB8X3Wn3Vtd2suvTMk1tMsqMDDD0ZSR+Fd5XjP7LHhy/8J+DNf0bVhELy21uZX8p96/6iDoa9moAKKKKACiiigArmviF/wAgG1/7C2mf+l8FdLXNfEL/AJANr/2FtM/9L4KAOlooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5r4Zf8k28J/9gm0/9EpXS1zXwy/5Jt4T/wCwTaf+iUoA6WiiigAooooAKKKKACuI+Fn+o8U9f+Rhvuv++K7evjHWfj14n8DeMvF2jaRYaLLaprl64a5hlZ8+aw6rIB/CO1AH2dRXxX/w1X44/wCgV4b/APAef/49R/w1X44/6BXhv/wHn/8Aj1AH1P8AFr/kmPij/sHzf+gmum0//jwts/8APJf5CviHxD+0r4x17Qr/AEq707QI7e8haCRoreYOFYYOMykZ+oNfbumnOnWp6ZiQ4/AUAWKKKKACiiigAooooA4e8/5LdpH/AGLt7/6U2tdxXjPxd8e6X8N/iX4f1rXIL24tbjSLyzRLNFZw5mt3yQzKMYU9/wAKxv8AhqvwP/0CvEn/AIDwf/HqAPf6K8A/4ar8D/8AQK8Sf+A8H/x6j/hqvwP/ANArxJ/4Dwf/AB6gD0r4a83njTp/yME/T/rjDXa15h8BPEth4u0fxPrWlJcx2t1rkzqlzGqOv7mHghWYfrXp9ABRRRQAUUUUAFc18Qv+QDa/9hbTP/S+CulrmviF/wAgG1/7C2mf+l8FAHS0UUUAFFFFABRRRQACiiigAooooAKKKKACiiigAooooAKKKKACiiigArmvhl/yTbwn/wBgm0/9EpXS1zXwy/5Jt4T/AOwTaf8AolKAOlooooAKKKKACiiigAr8+/iB4C8Wa18RfF97pPhvVry0fWr0LNBau6t++Y8EDnrX6CV8faj8f9X8CeLPFui2Oi6dcRR67ev5krSBjmYjkA/7NAHj/wDwq3x5/wBCfrv/AIBSf4Uf8Kt8ef8AQn67/wCAUn+Feu/8NYeIv+hd0n/vuT/Gj/hrDxF/0Luk/wDfcn+NAHjt38NfG1nazXN14T1uK3hQvJI1nIAqjkk8dBX6O6ZkabaZGD5Kcf8AARXxn4k/aa13XfD+o6VcaBpSRXsDwMweTKhhjPWvszTSW061JABMSHj6CgCzRRRQAUUUUAFFFFAHyb+3J/yEPB//AFyuv5xV8u191/GXxD4X8L/ETQL7xzax3elSaTeQRQyWouR53nWxB2EYHyhua5j/AIW78Dv+hbtP/BHF/hQB8d0V9if8Ld+B3/Qt2n/gji/wo/4W78Dv+hbtP/BHF/hQBo/sU/8AJLNV/wCw1L/6Igr3+vLP2fdU0TWdE8UX3heAQaVLrsxiQQLCB+5h6KOg/L6V6nQAUUUUAFFFFABXNfEL/kA2v/YW0z/0vgrpa5r4hf8AIBtf+wtpn/pfBQB0tFFcz8QvG+j+AdDj1bxA062kk626+THvbewJHHphTQB01FeJ/wDDTPw9/wCe2qf+Ah/xo/4aZ+Hv/PbVP/AQ/wCNAHtlFeJ/8NM/D3/ntqn/AICH/GtrwZ8c/B3jDxNZaDor6g9/dlxGJLfYo2Izkk59EP44oA9Soorj9D+JHhjW7SwuNNv2mjvbw2EQ8pwfO2ltpBGR8ozk8UAdhRVeO9tJfJ8u6gfziwi2yA7yv3tvrjBzjpWLqnjLRbD7Ji8jujc38OnAWrrKY5ZSQu/B+UZBoA6KiqY1Swa9lsxfWpu4l3yQCZd6L6lc5AqO11vSruCWe11OxngiIWSSO4RlQnoCQcAmgDQoqJbmBrdp1mjMC7t0gcbRjOcnpxg5+lV4NV064tY7m3v7SW2kfy0lSZWRm/ugg4J9qALtFUJtZ0uCSKObUrKN5l3xq86guvTIGeR7ilXV9NbUHsF1CzN8gJa3Ey+YABk5XOelAF6isubX9NW3vJLe8gu5LWBrl4beVHk2AZyBnv2JwPenQa3p0i2++8t4Zp0R1gllQSDcAQCM9ee1AGlRWPZeI9Nn0qK/uZ47CGTeQt3IkbAK5Uk/MRjI9e4q3c6vptqtu11qFnCtwN0JkmVRIMZyuTzwc8UAXa5r4Zf8k28J/wDYJtP/AESldIrB1DKQVIyCDkEVzfwy/wCSbeE/+wTaf+iUoA6WiiigAooooAKKw9e8QjR7qCA6TrF95qlvMsbUyonOMMc8Gvnqy/aW1e28d6ro+oeFpL62S/lgtorVWjvI0VmAVozuDPgcgbcHNAH1DX50fEvQdYv/AImeMZrHStQuYTrd6oeG2d1z5zHGQOuGU/iPWvuCy+IP2m2jlbwl4vgLjJjl0whl9j81c38PPF/2SDxDu0HxJOJNcvZB5dgTsBcHaeeCP55oA+IP+EV8Q/8AQB1b/wAA5P8ACj/hFfEP/QB1b1/485P8K/Qn/hOh/wBCx4q/8Fp/xpf+E6H/AELHir/wWn/GgD88p/DWu28Ek8+i6nFDGu95HtZFVV9SSOBX6aaZ/wAg20/64p/6CK80+JHjL7X8P/EcC+HvE8JewlUSPp5CrlepO7pzz+Nb9r43WK1hT/hGvFLbY1GRpp54+tAHa0Vytl4yF1ewW3/CO+JIfNkWPzZrAqiZONzHPAHc11VABRRWbr+rf2PZx3BsNQvt8gj8uxg81xkE7iM/d46+4oA0qK+bPiR+0Pq3g/x/9gj8OGTSfsscn2e9Rra5Ltk5DZYY7fd6g16Z4Z+KX9t6al23gzxfalh919Oyre6tnkfgKAPFP25P+Qh4P/65XX84q+Xa+5PFd9pHif4kaWuv+ENXv7KHRLtls7rTdz7zcWw3opPYZBI6Bsd6nPh/4f8AP/FqtR6Z/wCQKP8AGgD4Uor7sOgfD/n/AItVqPrxog/xpDoHw/H/ADSnUT3/AOQIP8aAMn9in/klmq/9hqX/ANEQV7/XjPwx1qw8Nr4qs9L8J69BaHW5XSG1047EzFEMY3cdOgx1FesaLqP9q2C3Qs7yz3My+TeReXIMHGSvoeooAvUUUUAFFFFABXNfEL/kA2v/AGFtM/8AS+CulrmviF/yAbX/ALC2mf8ApfBQB0tcp8SfHFh8P9Aj1fVbPULu2e4W22WMau6swYgkMyjHy469SOK6uigDwn/hpvwp/wBC/wCLf/AKL/47R/w034U/6F/xb/4BRf8Ax2vdqKAPCf8Ahpvwp/0L/i3/AMAov/jtbvgj47eHfGHiqw0Cw0nxBa3d6XEcl5bRpECkbSHJEhPRD2Nes0UAFeH+Gvg3qOi33gu9jvLFJ9NfdqscbvsuCpfy3T5eWCyFeQOMele13cpgtZpQMmNGbB74Ga8jf4n6+nhHQdXm0jTY312ZIrPZNJIsY2sWMg2rydoCqDzk88YoAq6f8LvEypo2m3WoaVFpWl/2nHDcW7S/aSt3HKocgrt3K0mcA9B1NX7b4e63/Z/h6zktPDNmNIvtPnM9mZBJcx27MWLZQfMcgheeS2WqrcfFXXBbbDpWm2V9aaRcareJdTkq4ikeMRxbedx2Z56bgKePiPd2r+IL1bXdN5Oj+Uk1w32eJ7pDliP4FUnkjrxQMhsvhTrFlr11dQ3OnSHzrye1v5ZHMqGdHGHh2bX5YZy+CB0rOj+EHiKTSddguZ9IWfUrSzgO24ldWkhuFkdm/dDaCqnAAwOnvXRL8R9akjgsrew0uXVW1x9EaXzXFsxEXmCRSAW9AV56deeOn+H3i86/pUY1k2NnrH2q5tPs8U3EzQNh2jDfMQBgnrjvQBL4y8Hwat8P7/w1oi2ulRSoBCkUQSFSJBIVKrj5WIIbH941xk3ww1K/WWS+TRYlu9dstRuNOg3NapBCmx1XKDczjqCoB9aj+Jfi/wAReHfiQG06VptBsdGS9v7MKpJRppI2lU4zlfkbGcYU1m+HfE+s+IpfCGmax4gudJtLzQ5NRlvoTHFJdXAkKbNzKQNq/PgD60AUPiV4Tv08R63p/h/QluoNXGnLA6WUqrYLCy5SOQJ5SoQuSNykZPB4rodQ+GviK88drrMtzpT20WpSXUTiR45BAyMojMax7dwJ5YsS3fHSuR1T4h+Jn8P+DLiS/wBT23I1UXE2lwRebeJbqDHKFdSoHBLY7BsdhXtfwz1G91bwFod/qt3b3l7cWyySzwYCsT7AAAjoQAOQaAPOrX4RX9pomm21p/Y8F5HoN9pd3LHuXzppkwjEhMsoOck8+gNaL/D/AFl/E3hm7udP8N3en6Pa28fzSvHM8yIqtKxER37cHYpIHQnB6etUUCPH9D+FV3DD4ah1pdJvYNMttRimjcGRS9xKXjKhk7A8k4IPTNcX4p8Fa7oOlWunx6cut3svh4aSfKtZ5lgfzGO6KQRlVzkZDlMYByelfSlFAXKWiW8lpothbTACWG3jjcA5GQoB/lWP8Mv+SbeE/wDsE2n/AKJSulrmvhl/yTbwn/2CbT/0SlAHS0UUUAFFFFABWbpmg6Tpd3eXWm6bZ2t1eSGa5mhhVXmc9WYgZJNaVFABXwJ46+I/jLw98QfGFjo3iHULSyXW70rEj/KCZmHGenAHFffdefeHo/Evh2416AeH21CG51a4vIJ476JQYpCGUYbBBB3Aj2688AHxZ/wuL4h9P+Es1T0++P8ACk/4XF8Qz08Wapzx98f4V92DXPEn/QoTf+DCD/Gk/t3xJ/0J8v46jB/j/nn8QD4Nv/iv481CxuLO88UanLbXCGOVDJjcp6jIHev0U00k6dak9TEmfyFcN4wm8Va/4V1bSbXwu1tPfWz26Sy6jEFQsMZbbk4AJ6A9MV3ttGYreKNjuZECk+uBQBJRRRQAUUUUAZkmgaRLra6zJplk+rLGIlvGhUyhAc4DYyBzWnRRQBw95/yW7SP+xdvf/Sm1ruK8V+Mvj6x+GvxF8P63qdpc3cVxpN3ZpFb7dwYzW75JYjjCn8cVzX/DWHhz/oXtX/77j/xoA+j6K+cT+1h4b7eHtX/77j/xpP8AhrDw5/0L2r/99x/40AetfDUYvPGmP+hgn/8ARMNdrXlf7Pnia28YaL4o1uyt5be3utemdElI3AeRB1xx+pr1SgAooooAKKKKACua+IX/ACAbX/sLaZ/6XwV0tc/47tbu78Pqun2kl5cQ31lc+RGyKzrFdRSOFLsq52o2MkUAdBRXNf8ACR6p/wBCX4g/7/WH/wAk0f8ACR6p/wBCX4g/7/WH/wAk0AdLRXNf8JHqn/Ql+IP+/wBYf/JNH/CR6p/0JfiD/v8AWH/yTQB0tFc1/wAJHqn/AEJfiD/v9Yf/ACTR/wAJHqn/AEJfiD/v9Yf/ACTQB0jKHUqwBUjBBGQRWfJoeky6SulyaXYvpigKto1uhhAHQBMbf0rL/wCEj1T/AKEvxB/3+sP/AJJo/wCEj1T/AKEvxB/3+sP/AJJoAzfFPwy0DxDb2drIjWFlao8aW1lBAiBWOWxujJQn1Qqea6O38PaPBay28emWflTQx28waFW86ONdqK5I+cKOBnOKzv8AhI9U/wChL8Qf9/rD/wCSaP8AhI9U/wChL8Qf9/rD/wCSaANSDQtIt4LSC30uwihs3822jS3RVgfn5kAGFPJ5Hqar23hnSrXW01W1tIoblIpI0WNFRFMjhpH2gffYquW6nH1qn/wkeqf9CX4g/wC/1h/8k0f8JHqn/Ql+IP8Av9Yf/JNAG1LptjNdSXM1lbSXMkH2Z5WiUu8WSfLJxkrkk7enNVbnw5odzp0Gn3OjabNYW/8AqbaS1Roo/wDdUjA/AVn/APCR6p/0JfiD/v8AWH/yTR/wkeqf9CX4g/7/AFh/8k0AbDaTpzTWUrWFoZbJWS1cwrugVhtYIcfKCAAcYyOKdpmm2Ok2i2ul2VtZWqksIbaJY0BPJO1QBzWL/wAJHqn/AEJfiD/v9Yf/ACTR/wAJHqn/AEJfiD/v9Yf/ACTQB0tFc1/wkeqf9CX4g/7/AFh/8k0f8JHqn/Ql+IP+/wBYf/JNAHS0VzX/AAkeqf8AQl+IP+/1h/8AJNH/AAkeqf8AQl+IP+/1h/8AJNAHS1zXwy/5Jt4T/wCwTaf+iUo/4SPVP+hL8Qf9/rD/AOSas+BbG50vwR4esL6Pyru1063gmj3BtrrGqsMjIOCD04oA3KKKKACiiigAooooAKKKKAKesapY6Lps+oatdwWdlAN0k8zhUUZxyT7kCotB1vTPEGnLf6LfQXtozFPNhbcAw6g+hHoa574ueHT4n8EXVjFb3txcpNDPAllJEkokSRSCPNIQ4GSQx5AOOcVm/BXwtrHhzSNbufEjAaprOqS6jJEGRjEGCgBigCljtJO3jkelAHolFFFABRRRQAUUUUAFFFFAHzd+1XrGjaJ4m8MXPiPw9H4hs5LK6ijtJLlrcRyeZAfM3KCTwCMe9eKHx/8ADvB/4tLaf+Du4/wr618T6NpevfGLRbTXNNstStU0G8lSG8gWZFf7RbDcFYEA4JGfet3/AIVx4H/6E3w3/wCCuD/4mgD4tPj/AOHfOPhLaf8Ag7uP/iaP+E/+Hef+SS2mP+w3P/8AE19pf8K48D/9Cb4b/wDBXB/8TR/wrjwP/wBCb4b/APBXB/8AE0AeffsoX+n6l4G1660fSk0ixk1yYxWaTNMIx5EHG9uT+n0r2uuB+EthZ6Z/wmFpptpbWdrHr8wSG2iEaKPJh4CjAH5V31ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcPef8AJbtI/wCxdvf/AEpta7ivnT9qHxrrHgDxX4Z1bw48Md7PY3dq7yxiQCMyQNwDxnKjmvHf+GlPiL/z/WH/AIBpQB920V8J/wDDSfxF/wCf2w/8AkpP+GlPiL/z/WH/AIBpQB9cfDUj7Z40x/0ME/8A6Jhrta8Y/ZY8Raj4q8F6/q+svG97ca3MXMcYjA/cwcYH9ea9noAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDh7z/kt2kf9i7e/+lNrXcVw95/yW7SP+xdvf/Sm1ruKACiiigDi/huzNeeM9zMSNfmAye3kw12lcV8Nf+Pzxp1/5GCfr/1xhrtaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA4e8/5LdpH/Yu3v8A6U2tdxXD3pA+NukknH/FO3v/AKU2tdvvX+8PzoAWik3r/eH50bl/vD86AOM+G3/H5404I/4qCbr/ANcYa7SuK+GhBu/GmMf8jBP0Of8AljDXa0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRXFfGDxBqXhnwPcajo5jinE8MUl1JF5q2kbyBXmK9woOf58UAdBrPh3R9aljl1bTLS8kjQxo00YYqpIJXPoSqnHsKoHwJ4VOc+H9N55/1C14BYeNta0TTvEd3o2qpfW134n8m41xol2RxfZ0IcD7iBmAG4jaM+4rsvCPjTxh4i1nwxpS6xo8b3Vhc3V1dwWv2iObyrgICmGUAlTgkErnJAPGAD03/hBPCvP/FP6byc/wCoWj/hBPCv/QA03rn/AFArA+IWL/4geAdGvHI0u4nuruWLOFnmgjVokb1GWZ8dDsFeXRy6+nx3itrPUzqN82vSTTyW19I62+m7MfZ5oMbIwuOGPLMRjPWgD6F0bR9O0W2e30ixtrKB5GlZIIwgZz1Y46k45NX68x8KS3uleL/iJpXh63ivILWW0u7azmuDDHHNPGTNGH2ttHyq+ACAX6DNX/hBq/ibVtDlk8SWEESLdXax3AvDLI5W6lXYUMa4VQAobJyFBwM4AB39FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAZmu6Fp2upZrqluZTZ3CXduyyNG0Uq5wyspBHUjrggkHIrToooAzND0PTtDS8GmQGI3lw11cO0jyPLK2MszMSTwAOuAAAMCtOiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiivMvjl8Q7jwLpNgmmJbfbr1yXnvI5nt7S3UqryyeSC4+aSJBju464wQD02mGWME5dRtIU89Ceg/HI/Ovz713xLruq6NcX+oatJdWN1agtOZ7/AMo6h8u5QSoT7QIjjZ/qgh+XnFVrO+uBrC7Eha0Nwwsxm98o6WWu/tPlkLva2w0u9yPNABwM78AH6IAggEHIPeivgXwpq/jC3sf+Jdd6hDqMVviRUbURKd0cCWSskamPLDaIs/K+cPxtz9WfATxzqnjPw3dReIYf+JxpciW11cR28kSSSbAWVg6KFmQ5WRV4BwR8rCgD06iiigAooooAKKKKACivOvjf42v/AAb4Zg/sOOF9a1GU2tl50csgMm0kKqRoxeRjhUU4XJyTgYPyP4u1/wAX3ayXN/eXz6rcW4Iwb8SBFjuFvFVHURgKTIJQPlQjEfyhsAH30JEJADqSSQBnqR1H4U5WDqGQhlIyCDkEV+ej3l2df+WOFYPtKi6UG+EY00NafZd52+YLf5YfLdR5pyN3OzOzpeo+NIZJJtOl1CO7RJnlMI1LP9qhneVWUJt+1eWHLIf3WwEtzmgD7zoryD4B/Eu78aDU9M1hLQXVoBNZXFsJhHe2m5o/MTzv3j7XQqXOMkgEZBr1+gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuI+Knw9svH2m2SSzR2upafKZrO6ktYrlEJGGV4pAVdDwSvHKqc8V29cD8S9G8f6peWLeA/Eljo1ukbi5S4t1kMjkjaRlG4xn0/HsAfMniD4H+PLKSWKLS47+OPTUs1mtNPsQskgYEgfvA+MA/6QVEp6EAEmqCfBzx4uqXE58P3AhfUUulb+zbE5iRpdzeV5u1T0xbgmN9wBOFTPvB8JfHA5/4uHow/7cE/+NUHwl8cOf8Ai4ej9f8AnwT/AONUAeK+FPgd47u7KG1uNMj08SQXEbS3en2UqxmREKbnLmbnGCwQtEQdgJLAfUHwj+HVl8O9Be1hlS61C5EZu7pbeOHfsQIqhUA+UAE5bLFmZiSWNcT/AMIl8cOf+Lh6P1/58E/+NV2vwy0fx3pU2pnx74istajkWL7ILaARmIgvvzhF65T16Hp3AO7ooooAKKKKACiiigDkPif4HtPHnhqfTLmUQThJPs85hSYROyFc7XUjv1GGH8LKea+UvF3wK8eWNnPBbabDqaRQ2wEtlZWcYfy4nLhWDiYkEgZ2bpSctgqoP1D8TdH8d6rJpx8BeI7LRUjEn2pbi3WTzSduzGUbGMN6de/bij4S+OHP/Fw9H6/8+Cf/ABqgDwo/Bvx5/a8M/wDYE/kx6jJcs/8AZlh/q5DFtYRebsfvmAny48HB+ZsXNG+CHjq/kWFtLSzQ2D2DzXWnWIRJRIc5/eFyuORdKplPQArg17SfCXxw5/4uHo/X/nwT/wCNUv8AwiXxwzn/AIWFo3XP/Hgn/wAaoA7L4S/Day+HtlqJS5W91XUpRLeXUdslrG23dsWOBPkjVQx4HUse2AO9rzn4caH8RtM1yebxx4qsNY01rdkjgt7ZY2WXcpD5CLxtDDGe9ejUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV5b8Z/h54P8AGd1pV14x1250h4FeC38u8htxLnDEfvFOSNueO1epV5D+0T4P1vxbY+HP7AivGNjfG4nlsZUS4iTbjdGHdAW9twoA4MfAr4SEAjx3e4PT/ib2n/xuj/hRPwl4/wCK6vuRkf8AE3tP/jdeN634Q1/SJT4b1TT9btNQawJ+1zZEbrH5byQmTzjEbSNR5m4DcGxkDjGXpN79puNV1i3/ALcl07Tr6K5u75SwkZXlmVLyY+cB9sUzJ5YU4JDk5AcsAe8f8KK+Ev8A0PV96/8AIXtP/jdem/BjwB4T8FHWJPB+uXGrC78pLky3cU4iKBmUfu1GCRJnnsQa+TfAOkar4j0of2J4e1a/jBkt/Lt4pvsccojiO0P9oQDzhGRMW6ArtAJXb9T/ALO/hTWfCnh3VotesZLKW6u0miilmWRlQW8SlAQ74jVlZEDNu2qMgUAesUUUUAFFFFABRRRQB5j8aPAHhLxq2jyeMdcuNJ+ymVLYxXcUAlLhWYfvFOSBHnjtmvMx8CfhKenjq+6Z/wCQvaf/ABuvVvjR4BvPHuk6fBYXtvay2Uz3GycPsucxsvkuyEMsb7sMQc7c4FfM3xH+G3iDw1psjX9mr2cYhjkk+0SGzGQ8KySFpyyiJp1SA7RlFYuvDbgD0P8A4UT8Jf8Aoer7pn/kL2nT/v3R/wAKK+En/Q93vr/yF7T/AON14Ytz9rf+30fWE0hNWdf7QmdleGQLFL9ohJm+a9kWBzIM7csmCNybeu+HvgTXfG9lFd6NoLnTbiGSMXN5JNFbxEs4+ypi5DtaqSGyAz+YOQwDAgH0H8Hfhd4M8H69e6v4Q1+81a4Nt9jmWS9hnSNXKSDIjQEE7VIyeh6c165Xl/wS+HOoeAW8QSapqMeozanOkouCHM8gBc7pizHLnfg7TjjqSSa9QoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACqN1rGmWmpWunXWo2cGoXeTb20k6rLNjrsQnLY9hTtYsn1HT5LaK+u7B3KkXFqVEi4YNgblYc4wcjoT9a8F+MPwI1vxz4n0i4tvEssljFEYribU2DvEN2f3SRoobgnqR060AfQ1ef/Ffx9f+CX0SDSfDlxrt1qkskSxws4MWxQxYhI3ZhgkkAZwp61T8DfC/UPCmiQ2EHxA8UyFEVCP9GeJQowoiSaKUxqBgbQ2OK4/4z348Ca34O1PXfF3iaeEXFziaO2sGkg/cFfkAtgpLF1B3Z4zxnkAHB/FvWPH/AMR9QsvD0uha/pfheEg3l3Dod2RdyKMlxHtL7MjEaMRk4Zyn/LPz7VfDXivVRbaZF4K8Uad4S01xNFpyafP590SyLJI0giKtcMpJ3uAqhdqgAKh9b/4Xx4Y/6Hbx/wD+C7TP/jFH/C+PDH/Q7eP/APwXaZ/8Y/zigDnvht4s+J/gu11N08D6pcafKFgs9FGm3ka2ZAYrJF+7ZdmT8+5vMdiGJJ3NX0P8J/G2oeNtIv59Y8PXPh6/srn7NJZ3LMX/ANWjhyGRSoO/gYPTOea8Z/4Xx4Yx/wAjt4//APBdpn/xiuv+D1y3jk+J9Z0Pxh4mhtJNQjTzZLewWSYi2hBLqbYgEY2jGBgDjOSQD2+iuV/4RfV/+h78Sf8AfjTv/kWui0+3ltbKKCe7nvZUGGuJwgeT3YIqrn6KKALFFFVdTtHvrCa2ju7mzeQYE9sVEic9V3Aj8waAI77V9NsL2zs77ULO2u71ittBNOqPORjIRScsRkdM9RV6vAPjZ8Etd8d6hoH2DxHLNb2qzLcSaq6kxhmQjy1jjGSfmzkj7qjIrqvh98JtQ8H6SlpD8QfFEjKvlhY/INuig8COKaOUJ17HmgC58avGWs+FbbRbbw19g/tLU55Yh9rt559kaQs7OqQhnOML/CwGeQBkj5h+JF742+IGqRW+rDxY2g2flOq3OitHJJISqyMkES7NwDuVDv8AcUjzMtg+0/GTUh4C8ReENS17xd4nmgZrtVnitrBpYf3aj5R9nCncSAc59sda5/8A4Xx4Y/6Hbx//AOC7TP8A4xQB4tfaHr+tXlqdU0LxFBoWlgW1lpkOnyed5O1mABEQjDMyr5kpGS0u8I+Co6Hwtf8Ajzw7PqviK1HiWHW7+MRRadYaTJ5EZRgqLOskflrGseRGsYYgDGYx19I/4Xx4Y/6Hbx//AOC7TP8A4xR/wvjwx/0O3j//AMF2mf8AxigD0P4BeOvEni1NcsfF8NtHqGli1JMVrLbufOjL4kWQD5hgDgAdxkEMfW68F+EOonx/4g8U6poXi3xTBbKtpEZ5rawWScgS9V+zlQB0GAD654x6h/wi+r/9D34k/wC/Gnf/ACLQB1VFQ2cL29pDDLcy3UkaBWnmCh5CB95ggVcn2AHsKmoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvAP2rpvDsMng1/GFrqFzpInu/MSxdVk/1Q24zj+PYevQHr0r3+vLPjB4a0jxZ4w8AaV4gtDd2E1zeB4vNePOLZnHKEHqqnr2+tAHy//aPwO/6Anjb/AL/w/wDxVA1H4Hf9AXxt/wB/of8A4r619Pf8M+fDD/oWf/J+6/8AjlH/AAz58MP+hZ/8n7r/AOOUAfMI1H4HY/5AnjX/AL/w/wDxVfQ37LMugTeHvEj+ELe+ttEOpL5Md84aYN9ni37sZH3s45P4dBsf8M+fDD/oWf8Ayfuv/jlX/hJ4d0vwpqvjTRtAtDaabb6lC0UXmPJgtaQM3zMSTyT1JoA9GooooAKKKKACiiigDwn9pjwVeePtZ8E6Hp91b2s0r3rCSfO0bY0bsM/w4/GvLv8AhlDxN31/Rvyl/wDia+iPH0rWPjnwXqclpqM9laG9897OxmujHviVVysSMRk+1av/AAnmkf8APn4k/wDCc1H/AOMUAfMX/DKHib/oP6N+Uv8A8TR/wyh4n/6D+jflL/8AE19O/wDCeaR/z5+JP/Cc1H/4xR/wnmkf8+fiT/wnNR/+MUAec/s3eDLzwBqXi3QNRure6niFnKZIA2zDiU455z/9avcK4LwPcHUfHvi/U4bTUYbK4hsUie8sJ7TeUWUMAJUUnGRnAPUc813tABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcJ41H/FyPh0cf8AL1e8/wDbpJXd14L+1H4W1bxfeeCtK8PvFHfzT3YRpJTGOIQ55HqEYfiPWgD3qiviP/hnX4m/8/Fl/wCDBv8ACl/4Z2+J3/PzZf8Agwb39v8AOaAPtuuP8HjHjPx5x11C27/9OUFfKZ/Z1+Jv/PxZH/uIN/hXuv7MnhvVPCOj+JtE1+SOTUrfUkaRo5TIMNbQsoyeeAQPw9KAPZ6KKKACiiigAqO6njtbaa4uHCQxIZHY/wAKgZJ/KpK8o+MnhjWte1rSprTS5tb0iKzuomsYrxLfy7lwBFOwZlDgcjHJHUCgD0zSNStNY0u11HTJhPZXUaywygEB0IyDg81br5l1H4Z+N307w9DLbahLDa6LbWscVjewpJp9zHy5BaRV5OPnQscDGCK9U+H3hPULPxb4m1rxCl59olv2bTy18zRmBokBIiV9gJYN1UHjsKAO0l13TYtcXR3u0GpG3N2YQCSsION7EDCjPGSRntWVpHj/AMJ6xZ6jd6Z4g065ttOTzLuRJhiFOfmb24PPSud0OYab8XfHFvdxb77UrW0u9PRmANzBHEUaNCePlk3Ej/poD0rm/B1l4xj8QeKfE2v+BXXWrqx8iytlv7X7OIo2Xy7cYcnc2SzOwA+XAA4BAPRrXx94WvPD11rtnrVtc6TavsuLiHc4hPH3wASo5ByRjHPSumRldVZGDKwyCDkEV4h4VhvPDfgvx9rXxF0RtOvtUVp7xnuIXiuiyMiwQpG7EADao3Hcxf8AAdp8PfDuvWHh7wqdS1+/h+yabbw3Ol+TAYy6xAEM5QyZB9G6igDvKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArhPGv/JSfh1/19Xv/AKSSV3dcJ41/5KT8Ov8Ar6vf/SSSgDu6KKKACuP8Hf8AI6ePeB/yELbv/wBOUFdhXH+Dv+Rz8e9P+Qhbf+kUFAHYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWH4j8M2evXOnXNzPeW9zp7yPBLazmJl3oUYZHqD+FblFAHKf8IXH/ANB/xL/4Mno/4QuP/oYPEv8A4Mn/AM/5+tbXiL7Z/Yt2dMvbWwugmVurqPzI4QDlmZdy5wue4HrXmXhbxT4n1n4d6tql7ruk6ZFZ6hNHBr81ifJurNOBMsRcAbm4B3Yx0BPJAOz/AOEKixj+3/Ev/gyetPw74ettCa+e3nvLia9lWWaW6mMrMVjWMcn/AGUFZPwn1nWvEHgDSdU8TWi2up3CMzoqFAy7iEfaeV3LtbHv+FddQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBmeJtB07xPod1o+t27XOnXQUTRCV49wDBgNyEMOQOh56dK5eT4S+DJfDx0OXS7iTSzOlz5D6jcth0UqpBMmQACflBx0OMgV3dFAGX4c0HT/AA5pi6fpMc0dqrFwstxJO2T1+aRmb9a1KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Example of the reciprocal translocation t(9;22), which is a characteristic finding in chronic myelogenous leukemia (CML). A small, distal piece of chromosome 9 (indicated by the arrow in the left upper chromosome) is broken off and translocated to the distal chromosome 22, as illustrated by the derivative chromosome der (22)-. The chromosomal segment that was originally present in the normal chromosome 22 (below the arrow in the left lower chromosome) is translocated to the shortened chromosome 9 to form a derivative, large chromosome der (9)+.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3569=[""].join("\n");
var outline_f3_31_3569=null;
var title_f3_31_3570="Patient information: Headache (The Basics)";
var content_f3_31_3570=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?15/51/16179\">",
"         Patient information: Headache causes and diagnosis in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/15/36086\">",
"         Patient information: Headache in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?41/59/42931\">",
"         Patient information: Headache treatment in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/57/35731\">",
"         Patient information: Migraine headaches in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Headache (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/headache-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H471877300\">",
"      <span class=\"h1\">",
"       Are there different types of headache?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. There are different types of headache. The two most common types are:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Tension headaches",
"        </strong>",
"        &ndash; Tension headaches cause pressure or tightness on both sides of the head.",
"       </li>",
"       <li>",
"        <strong>",
"         Migraine headaches",
"        </strong>",
"        &ndash; Migraine headaches often start off mild and then get worse. They often affect just one side of the head. They can cause nausea or vomiting, or make you sensitive to light and sound.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H471877307\">",
"      <span class=\"h1\">",
"       Is there anything I can do to feel better when I have a headache?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Some people feel better if they:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Lie down in a cool, dark, quiet room (this works best for migraine headaches)",
"       </li>",
"       <li>",
"        Take non-prescription pain medicines (but check with your doctor before taking any new medicines if you have a health condition or already take prescription medicines)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H471877314\">",
"      <span class=\"h1\">",
"       Is there anything I can do to keep from getting headaches?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Some people find that their headaches are triggered by certain foods or things they do. To keep from getting headaches in the future, you can keep a &ldquo;headache diary.&rdquo; In the diary, write down every time you have a headache and what you ate and did before it started. That way you can find out if there is anything you should avoid eating or doing.",
"     </p>",
"     <p>",
"      Some common headache triggers include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Skipping meals or eating too little",
"       </li>",
"       <li>",
"        Having too little or too much caffeine",
"       </li>",
"       <li>",
"        Sleeping too much or too little",
"       </li>",
"       <li>",
"        Certain foods, such as red wine, aged cheese, and hot dogs",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some women get migraine headaches just before they get their period. If that happens to you, mention it to your doctor or nurse. There are medicines that can help.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H471877321\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See a doctor or nurse right away if:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Your headache comes on suddenly, quickly becomes severe, or could be described as \"the worst headache of your life\"",
"       </li>",
"       <li>",
"        Your headache is severe and you also have a fever or stiff neck",
"       </li>",
"       <li>",
"        You also have a seizure, personality changes or confusion, or you pass out",
"       </li>",
"       <li>",
"        Your headache began right after you exercised or had a minor injury",
"       </li>",
"       <li>",
"        You have not had headaches before and you also have weakness, numbness, or trouble seeing (migraine headaches can sometimes cause these symptoms, but you should be seen right away the first time these symptoms happen)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      You should also see a doctor or nurse if you get headaches often or your headaches are severe.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H471877328\">",
"      <span class=\"h1\">",
"       How is headache treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There are lots of prescription and non-prescription medicines that can ease the pain of headaches. There are also prescription medicines that can help prevent headaches from happening in the first place.",
"     </p>",
"     <p>",
"      The right medicine for you will depend on what type of headaches you get, how often you get them, and how bad they are.",
"     </p>",
"     <p>",
"      If you get headaches often, work with your doctor to find a treatment that helps. Do not try to manage frequent headaches on your own with non-prescription pain medicines. Taking non-prescription pain medicines too often can actually cause more headaches later.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H471877335\">",
"      <span class=\"h1\">",
"       What should I know if my child gets a headache?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Children can get the same types of headaches that adults get. But they can also get headaches in situations when adults don&rsquo;t usually get them. For instance, children often get headaches when they have a cold.",
"     </p>",
"     <p>",
"      Take your child to the doctor right away (without giving any medicines) if your child has a headache that:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Started after a head injury",
"       </li>",
"       <li>",
"        Is severe or happens with other symptoms, such as:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Fever (temperature greater than 100.4&ordm;F or 38&ordm;C)",
"       </li>",
"       <li>",
"        Vomiting",
"       </li>",
"       <li>",
"        Changes in vision or double vision",
"       </li>",
"       <li>",
"        Neck pain or stiffness",
"       </li>",
"       <li>",
"        Confusion",
"       </li>",
"       <li>",
"        Loss of balance or unsteadiness",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      You should also take your child to see a doctor or nurse if he or she gets headaches more than once a month.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H471877342\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/57/35731?source=see_link\">",
"       Patient information: Migraine headaches in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?15/51/16179?source=see_link\">",
"       Patient information: Headache causes and diagnosis in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?41/59/42931?source=see_link\">",
"       Patient information: Headache treatment in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/15/36086?source=see_link\">",
"       Patient information: Headache in children (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?3/31/3570?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15440 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-E708425CE9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3570=[""].join("\n");
var outline_f3_31_3570=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H471877300\">",
"      Are there different types of headache?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H471877307\">",
"      Is there anything I can do to feel better when I have a headache?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H471877314\">",
"      Is there anything I can do to keep from getting headaches?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H471877321\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H471877328\">",
"      How is headache treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H471877335\">",
"      What should I know if my child gets a headache?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H471877342\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/51/16179?source=related_link\">",
"      Patient information: Headache causes and diagnosis in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/15/36086?source=related_link\">",
"      Patient information: Headache in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/59/42931?source=related_link\">",
"      Patient information: Headache treatment in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/57/35731?source=related_link\">",
"      Patient information: Migraine headaches in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_31_3571="TMJ anatomy";
var content_f3_31_3571=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F50060&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F50060&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    Temporomandibular joint anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 498px; height: 490px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Anatomy of the temporomandibular joint with location of masseter and pterygoid muscles.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pratt A, Loiselle JM. Reduction of temporomandibular joint dislocation. In: Textbook of Pediatric Emergency Procedures, 2nd Edition, King C, Henretig FM (Eds). Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3571=[""].join("\n");
var outline_f3_31_3571=null;
var title_f3_31_3572="Artificial tears: Patient drug information";
var content_f3_31_3572=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Artificial tears: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24211?source=see_link\">",
"     see \"Artificial tears: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/15/38131?source=see_link\">",
"     see \"Artificial tears: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F136850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Advanced Eye Relief&trade; Dry Eye Environmental [OTC];",
"     </li>",
"     <li>",
"      Advanced Eye Relief&trade; Dry Eye Rejuvenation  [OTC];",
"     </li>",
"     <li>",
"      Bion&reg; Tears [OTC];",
"     </li>",
"     <li>",
"      HypoTears [OTC];",
"     </li>",
"     <li>",
"      Murine Tears&reg; [OTC];",
"     </li>",
"     <li>",
"      Soothe&reg; Hydration [OTC];",
"     </li>",
"     <li>",
"      Soothe&reg; [OTC];",
"     </li>",
"     <li>",
"      Systane&reg; Ultra [OTC];",
"     </li>",
"     <li>",
"      Systane&reg; [OTC];",
"     </li>",
"     <li>",
"      Tears Again&reg; [OTC];",
"     </li>",
"     <li>",
"      Tears Naturale&reg; Forte [OTC];",
"     </li>",
"     <li>",
"      Tears Naturale&reg; Free [OTC];",
"     </li>",
"     <li>",
"      Tears Naturale&reg; II [OTC];",
"     </li>",
"     <li>",
"      Viva-Drops&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F136851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Teardrops&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10017693\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691824",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat dry eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691838",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat eye irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10017692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701550",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to artificial tears or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10017697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696947",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use this drug to treat contact lens irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10017698\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blurred eyesight. Use care when driving or doing other tasks that call for clear eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Short-term pain after use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10017700\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10017695\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 15 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10017696\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696549",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is used on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10017701\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10017702\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11119 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-3918385851-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3572=[""].join("\n");
var outline_f3_31_3572=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136850\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136851\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017693\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017692\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017697\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017698\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017700\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017695\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017696\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017701\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017702\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24211?source=related_link\">",
"      Artificial tears: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/15/38131?source=related_link\">",
"      Artificial tears: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_31_3573="Xillix Barretts high grade";
var content_f3_31_3573=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53968&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53968&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 557px\">",
"   <div class=\"ttl\">",
"    Autofluorescence images of Barrett's esophagus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 537px; height: 509px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Examples of Barretts esophagus with high-grade intra-epithelial neoplasia imaged with the LIFE-II system. The images on the left show the views obtained with the fibre optic white light mode of the system, the images on the right show the corresponding views obtained with LIFE.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.Barrett.nl. Copyright &copy; Amsterdam Esophageal Research Foundation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3573=[""].join("\n");
var outline_f3_31_3573=null;
var title_f3_31_3574="Intracranial translucency";
var content_f3_31_3574=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F75261&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F75261&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intracranial translucency",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 338px; height: 582px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Sagittal view of a normal fetal head and posterior fossa at 12",
"    <sup>",
"     4/7",
"    </sup>",
"    weeks of gestation.",
"    <br>",
"     (B) Sagittal view of&nbsp;a fetal head at 12",
"     <sup>",
"      6/7",
"     </sup>",
"     weeks of gestation with lack of visualization intracranial translucency (IT).&nbsp;This has been described as an early marker for open spina bifida.",
"     <div class=\"footnotes\">",
"      TH: thalamus; BS: brain stem; IT: intracranial translucency; CP: choroid plexus; FCM: future cistern magna; OB: occipital bone.",
"     </div>",
"     <div class=\"reference\">",
"      Courtesy of Ana Monteagudo, MD.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3574=[""].join("\n");
var outline_f3_31_3574=null;
var title_f3_31_3575="Parapneumonic effusion chest xray";
var content_f3_31_3575=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F73968&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F73968&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Parapneumonic effusion chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 366px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph showing loculated right parapneumonic effusion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charlie Strange, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3575=[""].join("\n");
var outline_f3_31_3575=null;
var title_f3_31_3576="Histol acral lentig melanoma";
var content_f3_31_3576=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F82287&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F82287&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acral lentiginous melanoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 286px; height: 578px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A: Low power light photomicrograph of an acral lentiginous melanoma shows a thickened stratum corneum, which is characteristic of acral sites. There is a lentiginous array of atypical melanocytes along the dermo-epidermal junction with foci of confluent melanocytic growth (black arrows). Panel B: Medium power photomicrograph shows extensive pagetoid spread of single cells into the epidermis (black arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Vincent Liu, MD and April Wang Armstrong, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3576=[""].join("\n");
var outline_f3_31_3576=null;
var title_f3_31_3577="Staging and treatment of Merkel cell carcinoma";
var content_f3_31_3577=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Staging and treatment of Merkel cell carcinoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/31/3577/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/31/3577/contributors\">",
"     Patricia Tai, MB, BS, DABR, FRCR, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/31/3577/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/31/3577/contributors\">",
"     Robert S Stern, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/31/3577/contributors\">",
"     June K Robinson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/31/3577/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/31/3577/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/31/3577/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Merkel cell carcinoma (MCC) of the skin is a rare, aggressive cutaneous malignancy that predominantly affects elderly Caucasians and has a propensity for local recurrence and regional lymph node metastases. A variety of other terms have been used to describe this tumor, including neuroendocrine or primary small cell carcinoma of the skin, trabecular cell carcinoma, and anaplastic cancer of the skin.",
"   </p>",
"   <p>",
"    The staging and treatment of MCC are discussed here. The clinical features and diagnosis of MCC are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6712?source=see_link\">",
"     \"Clinical features and diagnosis of Merkel cell (neuroendocrine) carcinoma and sebaceous cell carcinoma of the skin\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PRETREATMENT EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     TNM staging system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Historically, a number of staging systems were used in patients with Merkel cell carcinoma. These have now been consolidated into the 2010 tumor (T) node (N) metastasis (M) staging system that is supported by both the American Joint Committee on Cancer (AJCC) and the International Union for Cancer Control (UICC) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/1\">",
"     1",
"    </a>",
"    ]. This system is presented in the table (",
"    <a class=\"graphic graphic_table graphicRef75213 \" href=\"UTD.htm?41/35/42557\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stage I - Primary tumors &le;2 cm, without evidence of regional lymph node involvement",
"     </li>",
"     <li>",
"      Stage II - Primary tumors &gt;2 (T2 or T3) or a primary tumor with invasion into bone, muscle, fascia, or cartilage (T4)",
"     </li>",
"     <li>",
"      Stage III - Any primary tumor with regional lymph node disease",
"     </li>",
"     <li>",
"      Stage IV - Metastasis beyond the regional lymph nodes, regardless of the status of the primary tumor and regional nodes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This staging system was based upon an analysis of 4700 patients with Merkel cell carcinoma in the National Cancer Database registry [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/1\">",
"     1",
"    </a>",
"    ]. In that database, five-year survival decreased progressively with increasing stage from 60 to 80 percent for stage I to 20 percent for patients with stage IV disease (",
"    <a class=\"graphic graphic_figure graphicRef70983 \" href=\"UTD.htm?3/8/3215\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef82500 \" href=\"UTD.htm?10/20/10575\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef62228 \" href=\"UTD.htm?15/53/16222\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A subsequent analysis of 5823 prospectively enrolled cases of Merkel cell carcinoma from the National Cancer Data Base confirmed the validity of this staging system [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/2\">",
"     2",
"    </a>",
"    ]. This analysis found that approximately one-third of cases with clinical negative regional lymph nodes had microscopic involvement upon pathologic examination. Furthermore, for patients with nodal disease, relative survival was worse for those who had clinically apparent nodal involvement compared with those who had pathologically proven nodal disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Staging work-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation should include a complete examination of the skin and regional lymph nodes, with appropriate evaluation of any abnormalities that are detected. Suspected metastases in regional lymph nodes should be confirmed histologically with a fine needle aspirate",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    open biopsy.",
"   </p>",
"   <p>",
"    Imaging studies of the chest are particularly important, since small cell carcinoma arising in the lung can metastasize to the skin. Positron emission tomography with 18-fluorodeoxyglucose (18FDG), either alone or combined with computed tomography (CT), may be particularly useful and influence subsequent management in patients with stage II or III disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. However, large prospective series in patients with MCC are lacking to compare the utility of PET compared to other imaging modalities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     INITIAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment recommendations are based upon observational studies that consist primarily of single institution series gathered over many years.",
"   </p>",
"   <p>",
"    Wide local excision with negative margins is the initial approach for the primary lesion in most cases. The optimal management of the regional lymph nodes at the initial presentation is less clear. The potential options of observation, therapeutic or elective lymph node dissection, and radiation therapy (RT) are discussed below. The role of chemotherapy as part of a combined modality approach remains uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Primary tumor",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H272206302\">",
"    <span class=\"h3\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wide excision of the primary MCC tumor is the standard approach to the initial management of the primary tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. Excision with a margin of at least 1 to 2 cm of normal appearing skin is generally recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/6,7,9\">",
"     6,7,9",
"    </a>",
"    ]. For patients in whom margins are involved with tumor, RT may be useful in achieving local disease control [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Dose of radiation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Achieving negative margins with the initial resection appears to be important for long-term disease control. In a review of 661 published cases, 54 had no surgery, 167 underwent local excision, 140 underwent wide local excision, 44 underwent lymph node dissection, and 211 had surgery but the extent of the procedure was not specified [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/10\">",
"     10",
"    </a>",
"    ]. Complete excision was associated with a statistically significant improvement in overall survival and a trend toward better disease-free survival (p = 0.08).",
"   </p>",
"   <p>",
"    Because MCC often has extensive vertical growth and sometimes extends into muscle, deep margins are a potential site of failure. Mohs micrographic surgery has been advocated to improve local tumor control compared with standard wide excision [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. With this approach, 100 percent of all major borders, including the deep margins, are evaluated histologically. However, adjuvant RT may have a role in preventing locoregional recurrence even when Mohs surgery is used [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/11,14,15\">",
"     11,14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adjuvant RT is often recommended to the resection site for lesions thought to be at increased risk of local recurrence. A review of the literature and results from the Surveillance, Epidemiology, and End Results (SEER) database observed a significantly decreased incidence of local and regional recurrences when adjuvant RT was used [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. These observational results include many patients in whom the initial resection may have been incomplete or inadequate, and the precise role of adjuvant RT is less certain with a wide resection and negative surgical margins. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Adjuvant RT'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H272206309\">",
"    <span class=\"h3\">",
"     Radiation therapy alone",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients in whom surgical resection is not technically feasible or who are medically unfit for surgery, RT provides an alternative therapeutic approach [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/7,18,19\">",
"     7,18,19",
"    </a>",
"    ]. This approach can achieve an in-field disease control rate of 75 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/18\">",
"     18",
"    </a>",
"    ]. However, systemic relapse is common. Therefore the mainstay of treatment for MCC is surgery. Higher doses of radiation are recommended in this situation. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Dose of radiation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Regional lymph nodes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Clinically negative nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal management of the regional lymphatics in patients with MCC and clinically negative regional lymph nodes is uncertain.",
"   </p>",
"   <p>",
"    The only predictive factor that has been correlated with occult lymph node disease is the size of the primary tumor. A retrospective multi-institution database study analyzed 346 patients who underwent resection of their primary tumor and pathologic evaluation of the regional lymph node basin [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/20\">",
"     20",
"    </a>",
"    ]. Among the 54 patients with a primary tumor &le;1 cm in diameter, two (4 percent) had clinically positive regional nodes and none had occult disease. In contrast, 51 of the 159 (32 percent) cases with a primary tumor &gt;1 cm had lymph node involvement, including 13 with occult disease. However, others have reported a higher incidence of lymph node metastasis in patients with primary tumors &le;1 cm with routine use of immunostaining [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1261600\">",
"    <span class=\"h3\">",
"     Sentinel lymph node biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraoperative mapping of sentinel lymph nodes (SLNs) with SLN biopsy has been advocated to determine which patients might benefit from definitive treatment of their regional lymphatics. If the SLN is histologically negative, then the likelihood of other residual nodal disease is low. If the SLN contains tumor, a completion lymphadenectomy is indicated. This technique, which is widely used in patients with melanoma, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/2/26664?source=see_link&amp;anchor=H8#H8\">",
"     \"Evaluation and treatment of regional lymph nodes in melanoma\", section on 'Sentinel lymph node biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The role of this technique was studied in a single institution database series of 153 patients with clinically negative regional lymph nodes (stage I or II (",
"    <a class=\"graphic graphic_table graphicRef75213 \" href=\"UTD.htm?41/35/42557\">",
"     table 1",
"    </a>",
"    )) who underwent SLN biopsy over a 15 year period [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/22\">",
"     22",
"    </a>",
"    ]. Overall, 45 patients (29 percent) had lymph node involvement with tumor. Factors significantly associated with a positive lymph node included primary tumor size (25 percent &le;2 cm versus 45 percent &gt;2 cm) and the presence of lymphovascular invasion in the primary tumor (55 percent versus 4 percent for those without lymphovascular invasion). The presence of lymphovascular invasion was associated with an increased risk of recurrence and death from MCC, but involvement of the SLNs was not predictive of recurrence or death.",
"   </p>",
"   <p>",
"    Because wide local resection may disrupt the lymphatic drainage from the primary tumor, SLN mapping and biopsy should be performed at the time of wide local excision to identify patients who have occult nodal involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/7\">",
"     7",
"    </a>",
"    ]. The potential role of SLN biopsy in combination with wide local excision was illustrated by an observation study that showed that the risk of recurrence was 3.5 times lower in patients who underwent SLN biopsy compared with those who did not [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/23\">",
"     23",
"    </a>",
"    ]. There was a trend toward decreased regional-recurrence incidence at five years in patients who underwent operative staging of the regional draining basin [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data are too limited to determine if elective lymph node dissection, rather than completion lymph node dissection following a positive sentinel lymph node biopsy, prolongs survival and whether some patient subsets might benefit. The utility of this approach was suggested by a series of 35 patients with MCC [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/24\">",
"     24",
"    </a>",
"    ]. At 40-month follow-up, the patients who were initially treated with local excision alone had a 65 percent recurrence rate and a 29 percent mortality rate; the corresponding values for those who received locoregional therapy at presentation were 27 and 14 percent, despite the presence of more advanced disease in many of these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Clinically positive nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with clinical or radiographic suspicion of nodal involvement should have histologic confirmation of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/7\">",
"     7",
"    </a>",
"    ]. This may require either fine needle aspirate",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    open biopsy. If regional nodes are involved, definitive therapy with regional lymphadenectomy or, if not feasible, a therapeutic course of RT is indicated. Adjuvant RT to nodal regions after lymphadenectomy for extracapsular invasion or advanced nodal disease has been suggested [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although there are no randomized trials demonstrating a survival advantage from immediate treatment of regional lymph nodes, observational studies have demonstrated a five-year disease-specific survival of approximately 50 percent in patients with pathologic node involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Adjuvant RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;MCC is a radiosensitive neoplasm. Radiation therapy (RT) has been used postoperatively for patients at increased risk of local recurrence and to treat regional nodes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary tumor size &gt;2 cm",
"     </li>",
"     <li>",
"      Positive resection margins or tumors that closely approximate the surgical margin",
"     </li>",
"     <li>",
"      Lymphovascular invasion in the primary tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/25\">",
"       25",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Extracapsular extension of tumor outside nodes [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/23\">",
"       23",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Documented regional lymph node involvement or when regional lymph nodes were not pathologically staged",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Consensus guidelines from the National Comprehensive Cancer Network (NCCN) recommend the use of adjuvant nodal RT for patients with a positive SLB and when SLN biopsy has not been performed, although observation can be considered for small tumors that are widely excised and have no other adverse risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/7\">",
"     7",
"    </a>",
"    ]. Patients with a positive SLN biopsy or clinically positive lymph nodes who are treated with nodal RT alone have a regional control rate that is similar to historical outcomes in patients treated with completion lymph node dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the only prospective trial, patients with stage I MCC were randomly assigned to either adjuvant RT or observation after total wide local excision and RT to the tumor bed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/27\">",
"     27",
"    </a>",
"    ]. The study was conducted prior to the widespread introduction of sentinel lymph node biopsy and was stopped prematurely after the enrollment of 83 patients due to poor accrual. At a median follow-up of 58 months, adjuvant RT significantly reduced the likelihood of regional recurrence compared with observation (three-year rate 16.7 versus 0 percent), but there was no difference in overall survival.",
"   </p>",
"   <p>",
"    Therefore if sentinel node biopsy is not done, most radiation oncologists recommend treating both the surgical bed and the draining regional lymphatics, if technically feasible [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/7\">",
"     7",
"    </a>",
"    ]. It is important to treat all regional lymphatics to avoid geographic miss. Recurrence under shielding may occur. An adequate margin to cover surgical bed is advisable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Dose of radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized trials that define the optimal dose of radiation either to the primary tumor site or to regional lymphatics.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary tumor site - NCCN guidelines recommend a total radiation dose of 50 to 56 Gy in patients with clinically negative margins who are considered to be at significant risk for residual subclinical disease at the resection site [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/7\">",
"       7",
"      </a>",
"      ]. A dose of 56 to 60 Gy is recommended for those with microscopically positive resection margins and a dose of 60 to 66 Gy for those with grossly positive margins or an unresectable lesion. For stage I tumors that show aggressive features in histology or size, consideration should be made to include in-transit lymphatics and the draining lymph node basin.",
"     </li>",
"     <li>",
"      Regional lymph nodes - For patients with clinically negative regional lymph nodes that have not been assessed pathologically by either SLN biopsy or lymph node dissection, NCCN guidelines recommend a dose of 46 to 50 Gy [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/7\">",
"       7",
"      </a>",
"      ]. Higher doses are recommended for those with clinically evident lymphadenopathy or pathologic evidence of regional involvement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Adjuvant chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic chemotherapy has demonstrated clinical activity in patients with metastatic disease using chemotherapy regimens adapted from those for small cell carcinoma of the lung. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Metastatic disease'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"     \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are no randomized trials evaluating the efficacy of adjuvant chemotherapy in patients with MCC. Whether adjuvant chemotherapy is beneficial for patients at high risk for developing recurrent or disseminated disease is controversial.",
"   </p>",
"   <p>",
"    The most extensive data come from a study conducted by the Trans-Tasman Radiation Oncology Group [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. In this prospective phase II study, 53 patients were classified as being at high risk of recurrence based upon a recurrence after initial therapy, positive regional lymph nodes, a primary tumor &ge;1 cm, or gross residual disease after surgery. Treatment consisted of RT (50 Gy in 25 fractions over five weeks) and synchronous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    (area under the concentration x time curve [AUC] 4.5) plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    (80",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    IV days 1 to 3) during weeks 1, 4, 7, and 10.",
"   </p>",
"   <p>",
"    Doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    are calculated using the Calvert formula (total carboplatin dose (mg) = (target AUC) x (GFR +25)). The laboratory method used to measure serum creatinine may impact dosing. The Isotope Dilution Mass Spectrometry (IDMS) method (which will be used in all US laboratories by the end of 2010) may underestimate serum creatinine, and overestimate GFR in patients with normal renal function. If using IDMS to measure serum creatinine, the Food and Drug Administration (FDA) recommends that clinicians consider cap the estimated GFR at 125",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    when using the Calvert formula to calculate carboplatin dose.",
"   </p>",
"   <p>",
"    With a median follow-up of 48 months, the three-year overall survival, locoregional, and distant control rates were 76, 75, and 76 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/29\">",
"     29",
"    </a>",
"    ]. In a subsequent analysis, 40 of the patients were compared with historical controls treated with surgery and RT without adjuvant chemotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/28\">",
"     28",
"    </a>",
"    ]. Multivariate analysis suggested that chemotherapy did not affect overall survival compared to surgery plus RT without chemotherapy. However, these results are inconclusive due to the small size, long interval, and non-randomized nature of the data.",
"   </p>",
"   <p>",
"    Weekly",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    (AUC 2) may be a safer way to deliver synchronous chemotherapy during RT in patients with MCC [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/30\">",
"     30",
"    </a>",
"    ]. This approach reduced the incidence of febrile neutropenia and grade 3 skin toxicity compared with the three-weekly regimen of carboplatin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    as given in the Trans-Tasman Radiation Oncology Group study [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other observational studies have also not demonstrated a survival advantage from adjuvant chemotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/6\">",
"     6",
"    </a>",
"    ]. However, the interpretation of such studies is difficult since patients with poor prognostic factors or a larger tumor burden were more likely to be treated with adjuvant chemotherapy.",
"   </p>",
"   <p>",
"    For node-positive disease, adjuvant chemotherapy may be considered in NCCN guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/7\">",
"     7",
"    </a>",
"    ]. There are no results from randomized clinical trials to support adjuvant chemotherapy in MCC, but some researchers feel that this treatment can be justified in this group of patients who are at risk for distant failure, due to the initial chemoresponsiveness of metastatic Merkel cell cancer, especially in cases with an occult primary lesion. The use of systemic chemotherapy with radiation therapy to the regional lymph node basins has also been recommended on a case by case basis in patients who have extensive nodal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/23,29\">",
"     23,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Head and neck lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;MCCs arising in the head and neck region present a special problem, since achieving an adequate wide resection in patients is often particularly difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. In addition, the lymphatic drainage from primary tumors in this region is variable.",
"   </p>",
"   <p>",
"    Although there are no randomized trials in patients with MCC arising in the head and neck region, RT to the resection bed, in transit lymphatics, and regional lymph nodes is generally recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The largest experience is a retrospective analysis of 110 patients with head and neck MCC treated at three referral centers in Australia and Canada [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/31\">",
"     31",
"    </a>",
"    ]. At five years, local and regional control rates were 84 and 69 percent, respectively, and the five-year disease-specific survival rate was 62 percent. On multivariate analysis, age &gt;70 years, primary tumor size &gt;1 cm, and the presence of nodal metastases were all associated with an increased risk of death. When the analysis incorporated age and disease stage, there was a trend toward improved disease-specific survival with combined surgery plus RT (p = 0.08).",
"   </p>",
"   <p>",
"    Analyses of other large series and a review of the literature have also concluded that the inclusion of RT to the tumor bed and regional lymphatics as part of the initial treatment improves local and regional tumor control [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12500421\">",
"    <span class=\"h2\">",
"     Unknown primary",
"    </span>",
"    &nbsp;&mdash;&nbsp;In rare instances, MCC is diagnosed pathologically based upon lymph node involvement or other distant sites in the absence of an identifiable primary tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/34\">",
"     34",
"    </a>",
"    ]. The natural history of MCC in this situation is variable. Management should be individualized based upon the specific pattern of disease presentation and is based upon that for patients with an identifiable primary tumor and clinically positive lymph nodes or distant metastases. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Clinically positive nodes'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H15\">",
"     'Metastatic disease'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     RECURRENT DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Merkel cell carcinoma locoregional recurrences are frequent. Although locoregional recurrences are associated with a relatively poor prognosis, some patients with disease limited to locoregional sites can be salvaged with multimodality therapy.",
"   </p>",
"   <p>",
"    In a single institution series of 70 patients who had a locoregional recurrence as their first site of recurrence, the three-year overall survival after the initial recurrence was 39 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/35\">",
"     35",
"    </a>",
"    ]. The potential role of a multimodality approach was illustrated by a single institution series of 46 patients with recurrent Merkel cell carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/36\">",
"     36",
"    </a>",
"    ]. Mean survival was longer for patients treated with a combined modality approach (chemotherapy, radiation,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    surgery) compared to those treated with a single modality (37 versus 18 months).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     METASTATIC DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with advanced Merkel cell carcinoma (MCC), our approach is to use a combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    , based upon the experience and results in patients with small cell carcinoma of the lung. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link&amp;anchor=H116211046#H116211046\">",
"     \"First-line chemotherapy for patients with extensive stage small cell lung cancer\", section on 'Platinum plus etoposide'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a literature review, 21 of 31 (68 percent) patients showed some response (complete or partial remission or minor response) to systemic chemotherapy when all non-distant recurrences were combined by adding the local, nodal, and locoregional recurrences together [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/37\">",
"     37",
"    </a>",
"    ]. For those with distant recurrences, the overall response rate was 61 of 103 (59 percent). There was no significant difference among the regimens. The responses, including complete remission, are frequently of short duration [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/38-40\">",
"     38-40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The impact of systemic chemotherapy on survival in patients with metastatic MCC is unclear. In the above review of 204 patients who were treated with chemotherapy, median overall survival was 22 months (range 1 to 118 months), and the two- and five-year survival rates were 36 and 17 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/37\">",
"     37",
"    </a>",
"    ]. However,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    -based chemotherapy is toxic, especially in this relatively elderly population. The substitution of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    for cisplatin may mitigate chemotherapy-related toxicity. Six definite and one probable toxic deaths were observed in this series (3.5 percent). Tumor lysis syndrome has also been reported following treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Combining chemotherapy and RT may provide better palliation of advanced locoregional disease compared to chemotherapy alone [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. In one series of 27 patients with advanced locoregional MCC, chemotherapy produced responses in 18 (69 percent), which were mostly complete (41 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/42\">",
"     42",
"    </a>",
"    ]. However, in the absence of subsequent RT, the responses were short-lived. Thus, in patients with recurrent or locally advanced MCC and adequate performance status, combined chemotherapy and RT is probably the treatment of choice [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Newer approaches to advanced disease are required, given the short duration of response seen with standard chemotherapy regimens. Molecularly targeted approaches based upon emerging data regarding the expression of various receptors and signaling pathways may eventually offer some benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/44,45\">",
"     44,45",
"    </a>",
"    ], and patients should be enrolled in clinical studies whenever possible. The potential for immunotherapy in MCC, for which the emerging role of the MCPV in pathogenesis and the frequent association of the disease with relative immunocompromise provide the rationale, remains to be explored.",
"   </p>",
"   <p>",
"    Like other neuroendocrine tumors, MCC possesses receptors for somatostatin. These receptors have been demonstrated in vivo by octreoscan [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/46-49\">",
"     46-49",
"    </a>",
"    ]. In one case report, a patient with metastatic Merkel cell carcinoma had a complete response to treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    after receptors were demonstrated using octreoscan [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural history of MCC is variable. In some patients, localized primary tumors can be indolent and well controlled by local excision alone [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Significant favorable prognostic factors for overall survival are initial localized disease, female sex, age less than 65 years, and the absence of comorbid conditions, even after adjusting for the size of the primary lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/10,52\">",
"     10,52",
"    </a>",
"    ]. The presence of nodal disease is the most powerful predictor of survival and risk for developing distant metastatic disease. In one series, the median survival for patients with and without involved regional nodes was 13 versus 40 months, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The site of the primary lesion also impacts upon prognosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MCC arising in the head and neck region may be particularly difficult to treat. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Head and neck lesions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Truncal lesions, especially of the vulva or perianal region, have the worst prognosis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/29,37,54\">",
"       29,37,54",
"      </a>",
"      ]. These findings may be related to early versus late detection of lesions.",
"     </li>",
"     <li>",
"      Leg lesions are associated with a high incidence of local recurrence. One reason is that the lower extremity commonly has a poor blood supply in older patients, thus limiting the role of wide surgical resection. In addition, the lower leg is poorly tolerant of high-dose irradiation [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Following initial therapy, recurrences can be local, regional or distant. In a literature review, recurrences were local in 29 percent and occurred at a median of four months (range 1 to 96 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/10,37\">",
"     10,37",
"    </a>",
"    ]. In contrast, nodal or distant disease was a component of the recurrence in 33 and 33 percent of cases, respectively. Patients with an initial nodal recurrence had a significantly higher chance of developing subsequent distant metastases than those without a nodal recurrence.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Local recurrences usually occur within one year of initial therapy with a median time to recurrence of four months [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/6,10,37,56\">",
"       6,10,37,56",
"      </a>",
"      ]. The risk of a local recurrence was 43 percent in a series of 251 treated at MSKCC [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/6\">",
"       6",
"      </a>",
"      ]. However, it was only 8 percent after a margin-negative excision. The impact of a local recurrence on survival is controversial [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/57,58\">",
"       57,58",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The median time to develop clinically detectable nodal recurrence after resection of the primary lesion is seven to eight months. Among patients with nodal involvement either at presentation or at recurrence, 11 to 66 percent die of their disease within five years [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/24,36,59\">",
"       24,36,59",
"      </a>",
"      ]. As with local recurrences, multimodality approaches have been associated with an improved outcome following a nodal recurrence.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the literature review of 661 patients, 344 (52 percent) were alive at the last follow up, and the median overall survival was 31 months (range 0.5 to 94 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/10,37\">",
"     10,37",
"    </a>",
"    ]. Among patients who recurred and had salvage treatments, the median overall survival was 27 months (range 1 to 216 months). Combined modality therapy (surgery, RT, chemotherapy) is associated with the best salvage potential [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/36,42,43\">",
"     36,42,43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with MCC may benefit from frequent follow-up because of the high incidence of local, regional, and disseminated recurrences. Follow-up should be individualized according to risk factors and therapeutic options. It is not possible based upon existing data to make recommendations on the types and frequency of radiographic studies. Physical examination, with special emphasis on a total body skin examination and palpation of lymph nodes, is justified by the frequency of skin and nodal recurrence and the lack of expense or toxicity associated with clinical examinations. Serum neuron-specific enolase has demonstrated utility for early detection of recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3577/abstract/10,37\">",
"     10,37",
"    </a>",
"    ]. Routine chest radiograph is indicated, while CT scans of the chest, abdomen, or head may be indicated in patients with symptoms suggestive of recurrence. When recurrence is found, full staging work-up should be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Second primary cancers",
"    </span>",
"    &nbsp;&mdash;&nbsp;MCC is associated with an increased incidence of other skin tumors and hematologic malignancies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6712?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features and diagnosis of Merkel cell (neuroendocrine) carcinoma and sebaceous cell carcinoma of the skin\", section on 'Epidemiology and risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Initial management",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who present with localized or locoregional Merkel cell carcinoma (MCC), but without distant metastases, initial treatment is directed toward both the primary tumor and regional lymphatics.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend wide local excision of the primary lesion as a component of the initial treatment (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Radiation therapy (RT) is an alternative for patients who are not surgical candidates. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Primary tumor'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Dose of radiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients whose primary lesion is considered to have a significant risk for local recurrence, we recommend adjuvant RT rather than observation following surgery (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Factors that should be considered in deciding whether or not to use RT following resection include the size and anatomic location of the primary lesion, the status of the surgical margins, the presence of lymphovascular invasion in the pathology lesion, and the immunologic status of the patient. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Primary tumor'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Head and neck lesions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MCC has a high propensity for regional spread via the lymphatics. Regional lymph nodes should be evaluated clinically and if feasible, pathologically. Sentinel lymph node biopsy is generally not indicated for patients with a lesion arising in the head and neck region, since the lymphatic drainage from primary tumors in this region is variable. These patients are best managed with adjuvant nodal radiotherapy. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinically negative nodes'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Head and neck lesions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with a negative sentinel lymph node biopsy, we suggest observation rather than adjuvant RT (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). However, empiric treatment (adjuvant RT or elective lymph node dissection) may be a better alternative, especially for those with an increased risk of recurrence based upon the characteristics of their primary tumor. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Primary tumor'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Adjuvant RT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with clinical or radiographic evidence of lymph node disease, metastatic involvement should be confirmed pathologically. For patients with confirmed metastasis in the regional lymph nodes and for those with a positive sentinel lymph node biopsy, we recommend that definitive management also be directed at the regional lymphatics (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Such treatment may include either a therapeutic lymph node dissection or RT. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinically positive nodes'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Adjuvant RT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MCC is sensitive to chemotherapy using regimens based upon those for patients with small cell carcinoma of the lung. However, there are inadequate data to recommend adjuvant chemotherapy in this setting. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Adjuvant chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Recurrent disease",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients should be treated with multimodality salvage treatment. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Recurrent disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Metastatic disease",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with distant metastatic disease, either at initial diagnosis or at relapse following initial therapy, we suggest systemic chemotherapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Most experience has been accrued with regimens such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      , as is used in small cell carcinoma of the lung. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link&amp;anchor=H116211046#H116211046\">",
"       \"First-line chemotherapy for patients with extensive stage small cell lung cancer\", section on 'Platinum plus etoposide'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H15\">",
"       'Metastatic disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Merkel Cell Carcinoma. In: AJCC Staging Manual, Springer, New York 2009. p.325.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/2\">",
"      Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010; 63:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/3\">",
"      Belhocine T, Pierard GE, Fr&uuml;hling J, et al. Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma. Oncol Rep 2006; 16:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/4\">",
"      Concannon R, Larcos GS, Veness M. The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia. J Am Acad Dermatol 2010; 62:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/5\">",
"      Hawryluk EB, O'Regan KN, Sheehy N, et al. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: A study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center. J Am Acad Dermatol 2013; 68:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/6\">",
"      Allen PJ, Bowne WB, Jaques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005; 23:2300.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines. Available at: www.nccn.org (Accessed on May 15, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/8\">",
"      Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008; 113:2549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/9\">",
"      Swann MH, Yoon J. Merkel cell carcinoma. Semin Oncol 2007; 34:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/10\">",
"      Yu E, Tonita J, Gilchrist J. Merkel cell carcinoma of the skin. J Cutan Med Surg 2000; 4:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/11\">",
"      O'Connor WJ, Roenigk RK, Brodland DG. Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997; 23:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/12\">",
"      Gollard R, Weber R, Kosty MP, et al. Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer 2000; 88:1842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/13\">",
"      Senchenkov A, Barnes SA, Moran SL. Predictors of survival and recurrence in the surgical treatment of merkel cell carcinoma of the extremities. J Surg Oncol 2007; 95:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/14\">",
"      Boyer JD, Zitelli JA, Brodland DG, D'Angelo G. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002; 47:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/15\">",
"      Snow SN, Larson PO, Hardy S, et al. Merkel cell carcinoma of the skin and mucosa: report of 12 cutaneous cases with 2 cases arising from the nasal mucosa. Dermatol Surg 2001; 27:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/16\">",
"      Lewis KG, Weinstock MA, Weaver AL, Otley CC. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 2006; 142:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/17\">",
"      Mojica P, Smith D, Ellenhorn JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol 2007; 25:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/18\">",
"      Veness M, Foote M, Gebski V, Poulsen M. The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients. Int J Radiat Oncol Biol Phys 2010; 78:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/19\">",
"      Pape E, Rezvoy N, Penel N, et al. Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients. J Am Acad Dermatol 2011; 65:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/20\">",
"      Stokes JB, Graw KS, Dengel LT, et al. Patients with Merkel cell carcinoma tumors &lt; or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis. J Clin Oncol 2009; 27:3772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/21\">",
"      Sarnaik AA, Zager JS, Cox LE, et al. Routine omission of sentinel lymph node biopsy for merkel cell carcinoma &lt;= 1 cm is not justified. J Clin Oncol 2010; 28:e7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/22\">",
"      Fields RC, Busam KJ, Chou JF, et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol 2011; 18:2529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/23\">",
"      Bajetta E, Celio L, Platania M, et al. Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone. Ann Surg Oncol 2009; 16:2985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/24\">",
"      Smith DE, Bielamowicz S, Kagan AR, et al. Cutaneous neuroendocrine (Merkel cell) carcinoma. A report of 35 cases. Am J Clin Oncol 1995; 18:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/25\">",
"      Goepfert H, Remmler D, Silva E, Wheeler B. Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck. Arch Otolaryngol 1984; 110:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/26\">",
"      Fang L, Heath M, Nghiem P. Outcomes in sentinel lymph node positive or clinically positive merkel cell carcinoma treated with nodal irradiation alone (abstract). Int J Radiat Oncol Biol Phys 2007; 69:2972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/27\">",
"      Jouary T, Leyral C, Dreno B, et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol 2012; 23:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/28\">",
"      Poulsen MG, Rischin D, Porter I, et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys 2006; 64:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/29\">",
"      Poulsen M, Rischin D, Walpole E, et al. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07. J Clin Oncol 2003; 21:4371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/30\">",
"      Poulsen M, Walpole E, Harvey J, et al. Weekly carboplatin reduces toxicity during synchronous chemoradiotherapy for Merkel cell carcinoma of skin. Int J Radiat Oncol Biol Phys 2008; 72:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/31\">",
"      Clark JR, Veness MJ, Gilbert R, et al. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary? Head Neck 2007; 29:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/32\">",
"      Lawenda BD, Arnold MG, Tokarz VA, et al. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review. Ear Nose Throat J 2008; 87:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/33\">",
"      Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001; 127:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/34\">",
"      Tarantola TI, Vallow LA, Halyard MY, et al. Unknown primary Merkel cell carcinoma: 23 new cases and a review. J Am Acad Dermatol 2013; 68:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/35\">",
"      Grotz TE, Tarantola TI, Otley CC, et al. Natural history of merkel cell carcinoma following locoregional recurrence. Ann Surg Oncol 2012; 19:2556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/36\">",
"      Eng TY, Naguib M, Fuller CD, et al. Treatment of recurrent Merkel cell carcinoma: an analysis of 46 cases. Am J Clin Oncol 2004; 27:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/37\">",
"      Tai PT, Yu E, Winquist E, et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol 2000; 18:2493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/38\">",
"      Crown J, Lipzstein R, Cohen S, et al. Chemotherapy of metastatic Merkel cell cancer. Cancer Invest 1991; 9:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/39\">",
"      Pectasides D, Moutzourides G, Dimitriadis M, et al. Chemotherapy for Merkel cell carcinoma with carboplatin and etoposide. Am J Clin Oncol 1995; 18:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/40\">",
"      Redmond J 3rd, Perry J, Sowray P, et al. Chemotherapy of disseminated Merkel-cell carcinoma. Am J Clin Oncol 1991; 14:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/41\">",
"      Dirix LY, Prove A, Becquart D, et al. Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma. Cancer 1991; 67:2207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/42\">",
"      Fenig E, Brenner B, Katz A, et al. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 1997; 80:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/43\">",
"      Fenig E, Lurie H, Sulkes A. The use of cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of Merkel cell carcinoma. Am J Clin Oncol 1993; 16:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/44\">",
"      Davids MS, Davids M, Charlton A, et al. Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. J Clin Oncol 2009; 27:e97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/45\">",
"      Brunner M, Thurnher D, Pammer J, et al. Expression of hedgehog signaling molecules in Merkel cell carcinoma. Head Neck 2010; 32:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/46\">",
"      Meier G, Waldherr C, Herrmann R, et al. Successful targeted radiotherapy with 90Y-DOTATOC in a patient with Merkel cell carcinoma. A Case Report. Oncology 2004; 66:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/47\">",
"      Kau R, Arnold W. Somatostatin receptor scintigraphy and therapy of neuroendocrine (APUD) tumors of the head and neck. Acta Otolaryngol 1996; 116:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/48\">",
"      di Bartolomeo M, Bajetta E, Buzzoni R, et al. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group. Cancer 1996; 77:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/49\">",
"      Cirillo F, Filippini L, Lima GF, et al. [Merkel cell tumor. Report of case and treatment with octreotide]. Minerva Chir 1997; 52:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/50\">",
"      Hitchcock CL, Bland KI, Laney RG 3rd, et al. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg 1988; 207:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/51\">",
"      Savage P, Constenla D, Fisher C, et al. The natural history and management of Merkel cell carcinoma of the skin: a review of 22 patients treated at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol) 1997; 9:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/52\">",
"      Eng TY, Boersma MG, Fuller CD, et al. Treatment of merkel cell carcinoma. Am J Clin Oncol 2004; 27:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/53\">",
"      Morrison WH, Peters LJ, Silva EG, et al. The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1990; 19:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/54\">",
"      Ott MJ, Tanabe KK, Gadd MA, et al. Multimodality management of Merkel cell carcinoma. Arch Surg 1999; 134:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/55\">",
"      Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol 2004; 5:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/56\">",
"      Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002; 20:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/57\">",
"      Yiengpruksawan A, Coit DG, Thaler HT, et al. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991; 126:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/58\">",
"      Pitale M, Sessions RB, Husain S. An analysis of prognostic factors in cutaneous neuroendocrine carcinoma. Laryngoscope 1992; 102:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3577/abstract/59\">",
"      Pilotti S, Rilke F, Bartoli C, Grisotti A. Clinicopathologic correlations of cutaneous neuroendocrine Merkel cell carcinoma. J Clin Oncol 1988; 6:1863.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7609 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-217.117.136.88-5F405E172D-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3577=[""].join("\n");
var outline_f3_31_3577=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PRETREATMENT EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TNM staging system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Staging work-up",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      INITIAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Primary tumor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H272206302\">",
"      - Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H272206309\">",
"      - Radiation therapy alone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Regional lymph nodes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Clinically negative nodes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1261600\">",
"      - Sentinel lymph node biopsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Clinically positive nodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Adjuvant RT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Dose of radiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Adjuvant chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Head and neck lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12500421\">",
"      Unknown primary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      RECURRENT DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      METASTATIC DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Second primary cancers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Initial management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Recurrent disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Metastatic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/7609\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/7609|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/8/3215\" title=\"figure 1\">",
"      Merkel survival by node status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/20/10575\" title=\"figure 2\">",
"      Merkel relative survival by stage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/53/16222\" title=\"figure 3\">",
"      Merkel relative survival by extent of disease at diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/7609|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/35/42557\" title=\"table 1\">",
"      TNM stage Merkel",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6712?source=related_link\">",
"      Clinical features and diagnosis of Merkel cell (neuroendocrine) carcinoma and sebaceous cell carcinoma of the skin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/2/26664?source=related_link\">",
"      Evaluation and treatment of regional lymph nodes in melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=related_link\">",
"      First-line chemotherapy for patients with extensive stage small cell lung cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_31_3578="Extrapulmonary small cell cancer";
var content_f3_31_3578=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Extrapulmonary small cell cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/31/3578/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/31/3578/contributors\">",
"     Nasir Shahab, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/31/3578/contributors\">",
"     Donald C Doll, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/31/3578/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/31/3578/contributors\">",
"     Arthur T Skarin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/31/3578/contributors\">",
"     Rogerio C Lilenbaum, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/31/3578/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/31/3578/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/31/3578/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small cell carcinoma is a distinct clinicopathologic entity that usually arises in the lung but can also originate in a wide range of extrapulmonary sites. Small cell carcinoma is the preferred terminology, but these tumors have also been referred to as oat cell carcinoma or sarcoma, small cell neuroendocrine carcinoma, small cell tumor, anaplastic cell carcinoma, microcytoma, reserve cell carcinoma, undifferentiated carcinoma, Kulchitsky cell carcinoma, and carcinoma with amine precursor uptake decarboxylation (APUD) cell differentiation. These tumors are thought to originate from totipotent stem cells present in all tissues, although some small cell carcinomas may arise from more well-differentiated tumors.",
"   </p>",
"   <p>",
"    Extrapulmonary small cell carcinomas (ESCCs) are extremely rare; these tumors have been described most frequently in the urinary bladder, prostate, esophagus, stomach, colon and rectum, gallbladder, larynx, salivary glands, cervix, and skin. In addition, small cell carcinoma will occasionally present with metastatic disease, and a primary site cannot be identified (small cell carcinoma of unknown primary).",
"   </p>",
"   <p>",
"    This is illustrated by a recent study of 120 patients with ESCC, in which the most frequent site of origin was the female genital tract (26 percent), followed by gastrointestinal tract (23 percent), genitourinary tract (19 percent), head and neck (16 percent), unknown primary site (13 percent), and other sites (4.3 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/1\">",
"     1",
"    </a>",
"    ]. Similar findings have been reported by other groups [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although extrapulmonary undifferentiated large cell neuroendocrine carcinomas are distinct histologically, the natural history of such lesions is similar to that of ESCC, and the treatment approach is the same. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=see_link&amp;anchor=H24#H24\">",
"     \"Pathology of lung malignancies\", section on 'Large cell neuroendocrine carcinoma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The key features and general management of ESCCs will be reviewed here, followed by a discussion of aspects of ESCC specific to the more common sites. ESCCs arising in the cervix and with an unknown primary are discussed separately, as is Merkel cell carcinoma of the skin, which is in the differential diagnosis of these tumors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41174?source=see_link\">",
"     \"Neuroendocrine cancer of unknown primary site\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6712?source=see_link\">",
"     \"Clinical features and diagnosis of Merkel cell (neuroendocrine) carcinoma and sebaceous cell carcinoma of the skin\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5498?source=see_link&amp;anchor=H1336437714#H1336437714\">",
"     \"Small cell neuroendocrine carcinoma of the cervix\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW OF ESCC",
"    </span>",
"    &nbsp;&mdash;&nbsp;ESCCs have an aggressive natural history that is characterized by early, widespread metastases. Although some patients who present with locoregional disease may be cured by aggressive therapy, most relapse and the overall prognosis is poor, with less than 15 percent five year survival [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/4\">",
"     4",
"    </a>",
"    ]. In different studies, the median survival for limited and extensive disease ranges from 1.4 to 3.5 years and 8 to 12 months, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The initial clinical manifestations are often due to locoregional disease, and the presenting symptoms are indistinguishable from other histologic types of tumors arising in the same site. ESCCs also can present with symptoms from distant metastases or with paraneoplastic syndromes, as occurs with small cell lung cancer (SCLC). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of the risk factors, pathology, and clinical manifestations of lung cancer\", section on 'Paraneoplastic phenomena'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A variety of laboratory abnormalities have been reported with ESCC. As an example, paraneoplastic syndromes can result in hyponatremia, hypokalemia, or hypercalcemia, any of which may require specific treatment. Tumor-associated neuroendocrine markers have been elevated in some cases, although it is generally not useful to measure or monitor these proteins.",
"   </p>",
"   <p>",
"    Regardless of their site of origin, ESCCs have the same light microscopic appearance as SCLC. In most cases, electron microscopy can identify neurosecretory granules that establish the neuroendocrine origin of the tumor, but the absence of such granules does not rule out ESCC. ESCCs are often found in conjunction with other tumor types, and the presence of a small cell component usually determines the biologic aggressiveness of a tumor. The histopathology of SCLC is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=see_link\">",
"     \"Pathology of lung malignancies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation of a patient with ESCC should include evaluation of the primary tumor and regional lymph nodes to assess the extent of locoregional disease, and computed tomography (CT) of the chest to rule out a primary SCLC.",
"   </p>",
"   <p>",
"    Prior to treatment, patients should be evaluated to determine whether or not distant metastases are present. Imaging procedures that can be useful include abdominal and pelvic CT scans, bone scan, and positron emission tomography (PET) scanning. Magnetic resonance imaging (MRI) of the brain is recommended if neurologic symptoms are present. Bone marrow biopsy is indicated only if there are abnormal blood counts or findings on the peripheral smear, without other evidence of disseminated disease. Based on the results of such evaluation, patients with disease confined to a primary site",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    regional nodes are classified as limited disease, while all others are considered to have extensive disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the rarity of ESCC, the initial management of patients with locoregional disease is patterned after that for other tumor types arising in the same extrapulmonary site, as discussed below. In general this includes surgery and combined radiotherapy and chemotherapy. Despite aggressive locoregional treatment with surgery",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiation therapy (RT), relapse is common and adjuvant systemic chemotherapy is generally recommended, although all data are derived from case reports and no randomized clinical trials have been conducted. Despite adjuvant therapy, most patients develop metastatic disease and the prognosis is poor.",
"   </p>",
"   <p>",
"    The management of systemic disease with chemotherapy is patterned after the approach used in small cell lung cancer, that is, a platinum-based regimen with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    . Although objective responses are commonly observed, most are partial and of short duration [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. The prognosis for patients with disseminated disease is poor despite chemotherapy and is similar to that for patients with extensive small cell lung cancer. The choice of chemotherapy regimen, duration of treatment, role of maintenance therapy, and retreatment following relapse in patients are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"     \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because a lower rate of brain metastases has been reported in ESCC than in small cell lung cancer, prophylactic cranial irradiation is not routinely recommended, except perhaps for head and neck primary [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/1,4\">",
"     1,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     BLADDER ESCC",
"    </span>",
"    &nbsp;&mdash;&nbsp;ESCC of the urinary bladder is the most common site of ESCC in the genitourinary tract; it accounts for less than 1 percent of all bladder tumors. The pathology and management of ESCC of the bladder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/53/27481?source=see_link&amp;anchor=H35#H35\">",
"     \"Pathology of bladder neoplasms\", section on 'Small cell carcinoma'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11366?source=see_link\">",
"     \"Small cell carcinoma of the bladder\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PROSTATE ESCC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pure ESCC arising in the prostate is a rare disorder that is distinct from the far more common prostatic adenocarcinomas [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/8\">",
"     8",
"    </a>",
"    ]. The onset is younger (usually between the ages of 40 and 60), and the tumors tend to behave far more aggressively. In contrast to prostate adenocarcinoma, serum levels of the prostate specific antigen (PSA) do not correlate with disease activity and are not useful for posttreatment surveillance or as a surrogate marker of treatment benefit in the setting of advanced disease. While most cases arise de novo, on occasion, a prostate adenocarcinoma with foci of neuroendocrine differentiation may recur as a purely small cell cancer after androgen deprivation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Symptoms due to the primary tumor are the same as those seen with other prostate cancers, and reflect obstruction of urinary outflow and invasion of adjacent structures. Prostate ESCC metastasizes early in its natural history and symptoms can be due to distant disease. Brain metastases, which are extremely rare with adenocarcinoma, are more common with prostate ESCC [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A range of laboratory abnormalities has been reported with prostate ESCC. Like other small cell carcinomas, paraneoplastic syndromes such as Cushing's syndrome, peripheral neuropathy, membranous nephropathy, and hypercalcemia without bone metastases may be present [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Overview of ESCC'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36101?source=see_link\">",
"     \"Clinical presentation and diagnosis of prostate cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of the risk factors, pathology, and clinical manifestations of lung cancer\", section on 'Paraneoplastic phenomena'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Assay of serum tumor markers is of limited benefit. Prostate tumor markers (eg, prostate specific antigen, acid phosphatase) may be elevated, but levels are relatively low (typically &lt;2",
"    <span class=\"nowrap\">",
"     ng/ml),",
"    </span>",
"    even when metastatic disease is present [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Elevated levels of carcinoembryonic antigen (CEA) are also reported [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with other ESCCs, prostate ESCC is thought to arise from either neuroendocrine cells that are derived from APUD cells or totipotent stem cells present in the prostate [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. In many patients, ESCC is mixed with other histologic tumor types. Even a limited focus of ESCC usually portends a biologically aggressive course. The pathology of prostate tumors is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/52/24394?source=see_link&amp;anchor=H5#H5\">",
"     \"Interpretation of prostate biopsy\", section on 'Histologic features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of prostate ESCC is usually made from tissue obtained by transrectal needle biopsy. Before treatment, patients should be evaluated for a primary SCLC and fully staged to discover the extent of distant metastases (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Overview of ESCC'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Tumor staging for prostate ESCC uses the same TNM classification system as used for prostatic adenocarcinomas (",
"    <a class=\"graphic graphic_table graphicRef75565 graphicRef67222 \" href=\"UTD.htm?38/23/39294\">",
"     table 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Treatment and prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall outcome in men with ESCC of the prostate is illustrated by a series of 241 cases identified from the Surveillance, Epidemiology, and End Results (SEER) database over a 30 year period [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/21\">",
"     21",
"    </a>",
"    ]. In this series, 60 percent of patients had metastatic disease at presentation. The one, two, and five year survival rates were 48, 28, and 14 percent, respectively.",
"   </p>",
"   <p>",
"    Cases with early stage disease (ie, T1 or T2 tumors without lymph node or distant metastases) are rare [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Management of such cases needs to take into account the biologic aggressiveness of small cell carcinoma:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the prostate has been removed and foci of ESCC are found in the pathology specimen, we suggest that adjuvant platinum-based chemotherapy be given, as is routine for SCLC. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"       \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The role of adjuvant RT in this setting is uncertain. If the surgical margins are clear and the tumor volume is small, adjuvant chemotherapy without RT is appropriate. In men with an increased risk of local recurrence (eg, T2 lesions), we suggest that RT should be administered concurrently with chemotherapy, as is done for patients with limited stage SCLC. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9914?source=see_link\">",
"       \"Chemoradiotherapy for the initial treatment of limited stage small cell lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If ESCC is incidentally discovered in a biopsy specimen (T1 disease) and primary surgical excision is not planned, concurrent RT and platinum-based chemotherapy should be first-line therapy.",
"      <br/>",
"      <br/>",
"      However, most men with prostate ESCC are diagnosed with locally advanced (T3 or T4) lesions, usually in association with nodal",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      distant metastases. Treatment requires management of locoregional disease to control symptoms and systemic treatment (as used in SCLC) to prevent or palliate distant metastases [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"       \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      RT can dramatically decrease the size of the primary tumor and thus reduce local symptoms; however, responses generally are not durable. Because of the high probability of developing metastases, concurrent systemic chemotherapy is recommended even if disseminated disease is not present initially. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"       \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      When disseminated metastases are present, systemic chemotherapy is indicated [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/17\">",
"       17",
"      </a>",
"      ]. Most often a",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      -based combination (eg, cisplatin plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      ) is chosen [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/17\">",
"       17",
"      </a>",
"      ]. However, the optimal regimen has not been established, and reported clinical experience with any one regimen is scant [",
"      <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/24,25\">",
"       24,25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one series, 30 men with prostate cancer and neuroendocrine features based upon morphology alone or by immunohistochemistry received",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/4/35909?source=see_link\">",
"     estramustine",
"    </a>",
"    phosphate (EMP) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/24\">",
"     24",
"    </a>",
"    ]. Regression of measurable lesions was noted in four of nine cases of small cell carcinoma (44 percent), 6 of 13 poorly differentiated carcinomas (46 percent), 7 of 13 tumors with one neuroendocrine marker immunohistochemically detected (54 percent), and three of seven tumors without any positive staining (43 percent). Thus, the extent of neuroendocrine differentiation did not predict for a response to chemotherapy.",
"   </p>",
"   <p>",
"    The combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    was assessed in another series of 41 patients with androgen-independent prostate cancer and elevated serum neuroendocrine markers (either neuron specific enolase or chromogranin A) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/26\">",
"     26",
"    </a>",
"    ]. The objective response rate in 29 patients with measurable disease was 41 percent, and neuroendocrine markers responded in 33 percent. The median survival for all patients was 12 months.",
"   </p>",
"   <p>",
"    The addition of a third drug was attempted in one study of 38 men with small cell carcinoma of the prostate who received infusional",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/25\">",
"     25",
"    </a>",
"    ]. An objective response was seen in 22 of 36 assessable patients (61 percent), although there was considerable toxicity (100 percent grade 3 or 4 neutropenia, 68 percent infections), three toxic deaths, and median survival was only 10.5 months despite the high response rate.",
"   </p>",
"   <p>",
"    Other case reports document objective responses with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/27\">",
"     27",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/29/1498?source=see_link\">",
"     vincristine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no evidence that androgen deprivation therapy is useful in patients with pure ESCC [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/29\">",
"     29",
"    </a>",
"    ], although it is a reasonable component of initial therapy for men whose tumors are mixed adenocarcinoma and small cell carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link\">",
"     \"Initial hormone therapy for metastatic prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ESOPHAGEAL ESCC",
"    </span>",
"    &nbsp;&mdash;&nbsp;ESCC of the gastrointestinal tract develops most commonly in the esophagus and accounts for about 1 percent of all esophageal cancers [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/30-36\">",
"     30-36",
"    </a>",
"    ]. Most cases occur between the ages of 50 and 70, and approximately 80 percent of cases occur in men [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. The same factors associated with the development of squamous cell and adenocarcinoma of the esophagus may be risk factors for the development of ESCC; these include the presence of long standing achalasia, gastroesophageal reflux and Barrett's esophagus, smoking, and excess alcohol intake. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32250?source=see_link\">",
"     \"Epidemiology, pathobiology, and clinical manifestations of esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Like other types of esophageal cancer, the symptoms of ESCC reflect the presence of a mass. When the tumor is localized, progressive dysphagia and indigestion are common complaints; when the disease is more advanced, symptoms and signs can be due to intrathoracic spread or distant metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Weight loss and cachexia due to anorexia and decreased caloric intake and paraneoplastic syndromes may also be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients present with large fungating masses that protrude into the lumen of the esophagus. The tumors usually originate in the middle or lower third of the esophagus [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. Infiltration into surrounding mediastinal tissues",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    invasion of adjacent organs is common.",
"   </p>",
"   <p>",
"    The histologic appearance is the same as that of SCLC, although tumors frequently contain elements of adenocarcinoma or squamous carcinoma. Esophageal ESCC is thought to originate from totipotent stem cells [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/42\">",
"     42",
"    </a>",
"    ]. These cells retain the potential to differentiate into either mucin-producing or keratin-forming cells, which may explain the frequent coexistence of mixed tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=see_link\">",
"     \"Pathology of lung malignancies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis generally is established by endoscopy and biopsy, although imaging studies may be useful to identify the presence of a mass [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/40\">",
"     40",
"    </a>",
"    ]. In most instances, esophageal ESCC is locally advanced or disseminated at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prior to treatment, patients should be evaluated to rule out a primary SCLC or evidence of distant metastases (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Overview of ESCC'",
"    </a>",
"    above). There is no separate staging system for ESCC of the esophagus. ESCC of the esophagus and esophageal gastric junction are undifferentiated tumors and are included with squamous cell tumors for stage grouping (",
"    <a class=\"graphic graphic_table graphicRef62895 \" href=\"UTD.htm?13/38/13934\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Treatment and prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of ESCC of the esophagus is unsatisfactory, and the prognosis is poor even with aggressive treatment.",
"   </p>",
"   <p>",
"    For patients with limited disease (ie, no distant metastases), RT",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    surgery are used to palliate symptoms of obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/40\">",
"     40",
"    </a>",
"    ]. Even when disease initially is localized almost all patients recur with distant metastases. However, a small minority of patients who are treated with systemic chemotherapy have been long-term survivors in larger reported series [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of esophageal resection is uncertain for patients who present with localized disease because of the high risk of recurrence with disseminated disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/37,44\">",
"     37,44",
"    </a>",
"    ]. The theoretical benefits from resection must be weighed against the prolonged morbidity of an esophageal resection in patients with a relatively short life expectancy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients who do undergo aggressive surgery or RT for localized disease, adjuvant chemotherapy is recommended due to the chemosensitivity of small cell carcinoma. Although long-term survival has been reported in a few cases of esophageal ESCC, the prognosis is poor even with aggressive treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients who present with distant metastases",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    locally advanced disease, chemotherapy is used. RT may be of value for local symptom palliation. Chemotherapy, either as an adjuvant or for palliation of disseminated disease, is based upon the experience with SCLC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"     \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     GASTRIC ESCC",
"    </span>",
"    &nbsp;&mdash;&nbsp;ESCC arising in the stomach is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/30,45\">",
"     30,45",
"    </a>",
"    ]. Like other types of stomach cancer, gastric ESCC appears to be more common in Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. The average age at diagnosis is about 70 years [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/47\">",
"     47",
"    </a>",
"    ], and about three-fourths of cases are men [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/35/4661?source=see_link\">",
"     \"Epidemiology of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In most patients, gastric ESCC is locally advanced or disseminated at presentation. Symptoms can be due to the presence of a mass, ulceration and bleeding, invasion of adjacent structures, or systemic manifestations of malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. Findings on physical examination are nonspecific. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11850?source=see_link\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Grossly, gastric ESCCs are large tumors that typically arise in the upper one-third of the stomach [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/46,49\">",
"     46,49",
"    </a>",
"    ]. The histologic features are similar to those of SCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/46\">",
"     46",
"    </a>",
"    ]. Gastric ESCC is thought to arise from totipotent stem cells that can differentiate into a variety of cell types. In about one-half of cases, ESCC is the only tumor element present [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/46\">",
"     46",
"    </a>",
"    ]. A few cases of poorly differentiated large cell neuroendocrine gastric cancer have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=see_link\">",
"     \"Pathology of lung malignancies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Upper gastrointestinal endoscopy is the preferred procedure for initial evaluation, but",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    contrast studies may be useful in detecting the presence of a mass. Although the diagnosis is often made from a punch biopsy, differentiation from lymphoma, poorly or undifferentiated carcinoma, and other tumor types may be difficult or impossible with a limited sample. In these cases, the diagnosis of ESCC may require a larger surgical resection specimen [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11850?source=see_link\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior to treatment, patients should be evaluated to rule out a primary SCLC or evidence of distant metastases (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Overview of ESCC'",
"    </a>",
"    above). There is no separate staging system for ESCC of the stomach, and the TNM system is the same as that used for other gastric cancers (",
"    <a class=\"graphic graphic_table graphicRef57916 \" href=\"UTD.htm?11/6/11374\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Treatment and prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most patients present with advanced disease, total gastrectomy and lymph node dissection provide long-term survival in isolated cases [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/51\">",
"     51",
"    </a>",
"    ]. However, early relapse is common. Surgery alone is inadequate and adjuvant systemic chemotherapy is generally recommended.",
"   </p>",
"   <p>",
"    Metastatic disease is treated with systemic chemotherapy, and the platinum-based regimens used in SCLC are generally recommended. In Japan, anecdotal reports have utilized tegafur and uracil or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/16/38144?source=see_link\">",
"     mitomycin",
"    </a>",
"    regimens like those used for gastric adenocarcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/51\">",
"     51",
"    </a>",
"    ], but there are no data comparing these to platinum-based regimens. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"     \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The overall prognosis is poor [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. In one series, 34 of 67 patients died within one year, and only five patients (7.5 percent) survived two years [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     COLORECTAL ESCC",
"    </span>",
"    &nbsp;&mdash;&nbsp;ESCCs arising in the colon and rectum are rare [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/30,53\">",
"     30,53",
"    </a>",
"    ]. The epidemiology is similar to that of colorectal adenocarcinoma, with a slight male predominance; most cases are diagnosed between the ages of 50 and 70. No specific risk factor has been linked with the development of colorectal ESCC. Cases have been reported in patients with long standing ulcerative colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/54\">",
"     54",
"    </a>",
"    ] or HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/55-57\">",
"     55-57",
"    </a>",
"    ], but the role of these factors is unclear. Synchronous or multiple ESCC lesions have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/58-60\">",
"     58-60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical symptoms are indistinguishable from those of an advanced adenocarcinoma of the colon and may be due to the presence of an obstructing mass, bleeding, extension into adjacent organs, or systemic metastases. Paraneoplastic syndromes can occur with colorectal ESCCs and may contribute to the presenting symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Colorectal ESCC has the same macroscopic appearance as colorectal adenocarcinoma, and the microscopic features are the same as those of SCLC. The majority of lesions are distal; in a review of 75 cases, the most common site of origin was the rectum followed by the cecum, sigmoid colon, transverse colon, and ascending colon (38, 27, 17, 12, and 6 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=see_link\">",
"     \"Pathology of lung malignancies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tumors with mixed histology are often present. In a review of 38 cases, almost half were associated with overlying adenomas, one-fourth had areas of adenocarcinoma, and one-fourth had squamous changes in adjacent areas [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/53\">",
"     53",
"    </a>",
"    ]. The origin of these mixed tumors is thought to be a totipotent stem cell present in the submucosa that can differentiate into various cell lines [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Colonoscopy is the preferred approach for the evaluation of the entire colon, permitting biopsy of suspicious lesions and the detection of synchronous lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Before treatment, patients should be evaluated to rule out a primary small cell carcinoma of the lung or evidence of distant metastases (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Overview of ESCC'",
"    </a>",
"    above). There is no separate staging system for ESCC of the large bowel; patients should be staged using the TNM classification for colorectal cancers (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most cases have large primary tumors and lymph node or distant metastases at presentation. In a review of 38 cases of colorectal ESCC, 89 percent had lymph node involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/53\">",
"     53",
"    </a>",
"    ]. The liver is the most frequent site of metastatic disease, but metastases have been described at virtually all sites [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/53,54\">",
"     53,54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Treatment and prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even with aggressive therapy including the use of systemic chemotherapy, the overall prognosis is poor [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/53,60\">",
"     53,60",
"    </a>",
"    ]. In a review of 47 cases, the median survival was six months, and only 15 percent were alive at one year [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite rare reports of long-term survivors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/63\">",
"     63",
"    </a>",
"    ], surgery alone is inadequate therapy, even for apparently localized disease. Adjuvant RT for incompletely resected disease and systemic chemotherapy are widely recommended, although the effectiveness of a combined modality approach has not been established.",
"   </p>",
"   <p>",
"    The selection of chemotherapy regimens, either as an adjuvant after surgery or for the treatment of metastatic disease, is based upon the experience treating SCLC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"     \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In cases in which ESCC is mixed with another histologic tumor type, the natural history of the disease is determined by the presence of ESCC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     GALLBLADDER ESCC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary ESCC accounts for between 1 and 5 percent of carcinomas arising in the gallbladder [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/64\">",
"     64",
"    </a>",
"    ]. The epidemiology of gallbladder ESCC is similar to that of adenocarcinoma, suggesting common etiologic factors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/65-67\">",
"     65-67",
"    </a>",
"    ]. In a series of 53 patients, small cell carcinoma was twice as common in women, the median age at diagnosis was 64 years, and two-thirds had coexisting cholelithiasis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients typically present with a large tumor mass that is indistinguishable from other tumors arising in the gallbladder. The symptoms and findings on physical examination are secondary to the presence of a mass or obstruction of the biliary tract [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/65,68\">",
"     65,68",
"    </a>",
"    ]. In addition, gallbladder ESCC may be associated with paraneoplastic syndromes. Laboratory features are nonspecific and reflect obstruction of the biliary tract. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The microscopic findings are similar to those of SCLC. In some cases, ESCC is found in conjunction with adenocarcinoma or other histologic types of gallbladder cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/64\">",
"     64",
"    </a>",
"    ]. Tumors with mixed histology are consistent with the hypothesis that ESCC arises either from a totipotent stem cell or within foci of more differentiated tumors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=see_link\">",
"     \"Pathology of lung malignancies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Abdominal ultrasound is the preferred imaging modality for biliary tract disease. The mass may obstruct the biliary tree as well as the vessels of porta hepatis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/65\">",
"     65",
"    </a>",
"    ]. CT, endoscopic retrograde cholangiopancreatography (ERCP), and angiography can also be useful in staging and treatment planning, although laparotomy is often required to obtain tissue for a diagnosis and define the extent of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prior to treatment, patients should be evaluated to rule out a primary SCLC or evidence of distant metastases (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Overview of ESCC'",
"    </a>",
"    above). There is no specific staging system for gallbladder ESCC; tumors should be staged according to the TNM system (",
"    <a class=\"graphic graphic_table graphicRef70554 \" href=\"UTD.htm?6/41/6813\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Treatment and prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Almost all gallbladder ESCCs are either locally advanced or metastatic at diagnosis, and the prognosis is poor [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/64-67\">",
"     64-67",
"    </a>",
"    ]. In a series of 53 cases from the literature, those with disseminated disease had a median survival of 8 months, and one and two year survival rates of 28 and 0 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with localized disease, surgical resection may result in prolonged survival in occasional patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/70\">",
"     70",
"    </a>",
"    ]. However, the development of distant metastases in most patients has led to the use of systemic chemotherapy as adjuvant therapy in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chemotherapy is also used in the treatment for disseminated disease. Although there are no clinical trials of different regimens, the approach to systemic therapy is based upon the experience in SCLC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"     \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     LARYNGEAL ESCC",
"    </span>",
"    &nbsp;&mdash;&nbsp;ESCC can arise anywhere in the head neck region and occurs most frequently in the larynx [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/71-73\">",
"     71-73",
"    </a>",
"    ]. The epidemiology and risk factors for laryngeal ESCC are similar to that for other laryngeal tumors. Most patients are between the ages of 60 and 80, and there is a slight male predominance [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/71\">",
"     71",
"    </a>",
"    ]. Smoking, chewing tobacco, and excess alcohol intake have been associated with ESCC of the larynx [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/71\">",
"     71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/6/20583?source=see_link\">",
"     \"Epidemiology and risk factors for head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical features of laryngeal ESCC are similar to those of other laryngeal tumors and are due to the presence of a laryngeal mass [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/71\">",
"     71",
"    </a>",
"    ]. Cervical lymph node metastases are often the initial site of tumor spread, and the origin of the tumor in the larynx only becomes apparent when the patient later presents with hoarseness [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/74\">",
"     74",
"    </a>",
"    ]. In a review of 66 cases, cervical lymph node involvement was present in 35 (53 percent) at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/71\">",
"     71",
"    </a>",
"    ]. In addition, some patients have symptoms from paraneoplastic syndromes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/43/36537?source=see_link\">",
"     \"Overview of the diagnosis and staging of head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ESCC of the larynx grossly is indistinguishable from other tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/71\">",
"     71",
"    </a>",
"    ], while its histopathologic appearance is the same as that of SCLC. In addition to small cell carcinoma, large cell poorly differentiated neuroendocrine tumors have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/71\">",
"     71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=see_link\">",
"     \"Pathology of lung malignancies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although most tumors are comprised of pure ESCC, some have elements of squamous cell carcinoma or adenocarcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/74-77\">",
"     74-77",
"    </a>",
"    ]. These composite tumors are thought to arise in a common totipotent stem cell that can differentiate into various cell types.",
"   </p>",
"   <p>",
"    The differentiation of ESCC from other laryngeal tumors requires biopsy and histologic examination of the tumor. Tissue may be obtained from the tumor itself or from a cervical lymph node.",
"   </p>",
"   <p>",
"    Before treatment, patients should be evaluated to rule out a primary lung ESCC or evidence of distant metastases, which are often present at diagnosis (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Overview of ESCC'",
"    </a>",
"    above). Laryngeal small cell carcinoma is staged according to the TNM staging classification used for squamous cell carcinoma of the larynx (",
"    <a class=\"graphic graphic_table graphicRef66619 \" href=\"UTD.htm?22/14/22766\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Treatment and prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall prognosis of ESCC of the larynx is poor due to early spread of disease, with estimated two and five year survival rates of 16 and 5 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients without distant metastases, management of local and regional disease has relied upon surgery, RT, or a combined modality approach [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/74,76\">",
"     74,76",
"    </a>",
"    ]. Although occasional long-term survivors have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/72\">",
"     72",
"    </a>",
"    ], the local recurrence rate is high, especially when disease is present in the cervical lymph nodes, and distant metastases are almost always seen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/45/41689?source=see_link\">",
"     \"Treatment of locoregionally advanced (stage III and IV) head and neck cancer: The larynx and hypopharynx\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Systemic chemotherapy, used as an adjuvant following local treatment and for the management of patients who present with metastatic disease, may induce remissions and prolong survival [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/71,79,80\">",
"     71,79,80",
"    </a>",
"    ]. The chemotherapy approach is the same as that used for extensive SCLC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"     \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with metastatic disease, control of laryngeal disease can take precedence over systemic treatment if there is an imminent risk of respiratory obstruction. In such situations, RT is preferred followed by systemic chemotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SALIVARY GLAND ESCC",
"    </span>",
"    &nbsp;&mdash;&nbsp;ESCCs of the parotid, submandibular, and minor salivary glands account for about 1 to 2 percent of all salivary gland tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/82\">",
"     82",
"    </a>",
"    ]. There are no known risk factors for ESCC of the salivary glands. Most tumors occur between the ages of 50 and 70.",
"   </p>",
"   <p>",
"    The typical patient presents with a rapidly growing painless mass in a salivary gland [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/83\">",
"     83",
"    </a>",
"    ]. Less often, pain may be noted and some patients may present with symptoms due to a paraneoplastic syndrome.",
"   </p>",
"   <p>",
"    The histologic appearance of salivary gland ESCC is similar to that of SCLC. In addition to pure ESCC, tumors with concurrent features of squamous or ductal differentiation have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. Salivary gland ESCC appears to arise from stem cells of the salivary duct system capable of differentiation to ductal or neuroendocrine like cells [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/84\">",
"     84",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=see_link\">",
"     \"Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis is based upon histologic examination of a biopsy sample, from either a fine needle aspirate or a surgical resection specimen. Before treatment, patients should be evaluated to rule out a primary lung ESCC or evidence of distant metastases (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Overview of ESCC'",
"    </a>",
"    above). There is no separate staging classification for ESCC of the salivary glands, and these tumors are staged according to the TNM system (",
"    <a class=\"graphic graphic_table graphicRef61042 \" href=\"UTD.htm?34/52/35661\">",
"     table 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Treatment and prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decisions regarding therapy are largely based upon experience with other salivary gland tumors and anecdotal case reports. For patients who present without evidence of metastatic disease, surgical resection of the tumor, along with regional lymph node dissection, is the preferred treatment. Postoperative RT has been used to improve local control although there are no trials documenting its efficacy.",
"   </p>",
"   <p>",
"    Despite local treatment, most patients relapse with distant disease. Adjuvant systemic chemotherapy has been used based upon the chemosensitivity of ESCC to platinum-based regimens. Metastatic disease, whether present at diagnosis or developing after treatment of the primary tumor, is managed with systemic chemotherapy. Chemotherapy regimens are based upon those used for patients with SCLC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"     \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When compared to ESCCs arising in the larynx and other sites, those originating in salivary glands appear to have a better prognosis. In a retrospective analysis of 20 patients, the two year and five year survival rates were 70 percent and 46 percent respectively, compared to 16 and 5 percent for laryngeal small cell carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/31/3578/abstract/84\">",
"     84",
"    </a>",
"    ]. This may be due to early recognition of salivary gland abnormalities because of their superficial location, thereby permitting earlier diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Small cell carcinoma is a distinct clinicopathologic entity that usually arises in the lung but can also originate in a wide range of extrapulmonary sites. These tumors are thought to originate from totipotent stem cells present in all tissues, although some small cell carcinomas may arise from more well-differentiated tumors.",
"     </li>",
"     <li>",
"      Extrapulmonary small cell carcinomas are extremely rare; these tumors have been described most frequently in the urinary bladder, prostate, esophagus, stomach, colon and rectum, gallbladder, larynx, salivary glands, cervix, and skin. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview of ESCC'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although the initial clinical manifestations are often due to locoregional disease, extrapulmonary small cell carcinomas have an aggressive natural history that is characterized by early, widespread metastases. Although some patients who present with locoregional disease may be cured by aggressive therapy, most relapse and the overall prognosis is poor. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview of ESCC'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial evaluation of a patient with extrapulmonary small cell carcinoma should include evaluation of the primary tumor and regional lymph nodes to assess the extent of locoregional disease and computed tomography (CT) of the chest to rule out a primary SCLC. Prior to treatment, patients should be evaluated to determine whether or not distant metastases are present. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Staging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial management of patients with locoregional disease is patterned after that for other tumor types arising in the same extrapulmonary site. Despite aggressive locoregional treatment, relapse is common and adjuvant systemic chemotherapy is generally recommended, although all data are derived from case reports and no randomized clinical trials have been conducted. Despite adjuvant therapy, most patients develop metastatic disease. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of systemic disease with chemotherapy is patterned after the approach used in SCLC. Although objective responses are commonly observed, most are partial and of short duration. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"       \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/1\">",
"      Brennan SM, Gregory DL, Stillie A, et al. Should extrapulmonary small cell cancer be managed like small cell lung cancer? Cancer 2010; 116:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/2\">",
"      Ochsenreither S, Marnitz-Schultze S, Schneider A, et al. Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at Charit&eacute;. Anticancer Res 2009; 29:3411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/3\">",
"      Wong YN, Jack RH, Mak V, et al. The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004. BMC Cancer 2009; 9:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/4\">",
"      Walenkamp AM, Sonke GS, Sleijfer DT. Clinical and therapeutic aspects of extrapulmonary small cell carcinoma. Cancer Treat Rev 2009; 35:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/5\">",
"      Kim JH, Lee SH, Park J, et al. Extrapulmonary small-cell carcinoma: a single-institution experience. Jpn J Clin Oncol 2004; 34:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/6\">",
"      Sengoz M, Abacioglu U, Salepci T, et al. Extrapulmonary small cell carcinoma: multimodality treatment results. Tumori 2003; 89:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/7\">",
"      Soto DE, Eisbruch A. Limited-stage extrapulmonary small cell carcinoma: outcomes after modern chemotherapy and radiotherapy. Cancer J 2007; 13:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/8\">",
"      Mackey JR, Au HJ, Hugh J, Venner P. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J Urol 1998; 159:1624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/9\">",
"      Miyoshi Y, Uemura H, Kitami K, et al. Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy. BJU Int 2001; 88:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/10\">",
"      Sella A, Konichezky M, Flex D, et al. Low PSA metastatic androgen- independent prostate cancer. Eur Urol 2000; 38:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/11\">",
"      Tremont-Lukats IW, Bobustuc G, Lagos GK, et al. Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center experience. Cancer 2003; 98:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/12\">",
"      Erasmus CE, Verhagen WI, Wauters CA, van Lindert EJ. Brain metastasis from prostate small cell carcinoma: not to be neglected. Can J Neurol Sci 2002; 29:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/13\">",
"      Smith DC, Tucker JA, Trump DL. Hypercalcemia and neuroendocrine carcinoma of the prostate: a report of three cases and a review of the literature. J Clin Oncol 1992; 10:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/14\">",
"      Alshaikh OM, Al-Mahfouz AA, Al-Hindi H, et al. Unusual cause of ectopic secretion of adrenocorticotropic hormone: Cushing syndrome attributable to small cell prostate cancer. Endocr Pract 2010; 16:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/15\">",
"      Schwartz LH, LaTrenta LR, Bonaccio E, et al. Small cell and anaplastic prostate cancer: correlation between CT findings and prostate-specific antigen level. Radiology 1998; 208:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/16\">",
"      Leibovici D, Spiess PE, Agarwal PK, et al. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level. Cancer 2007; 109:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/17\">",
"      Amato RJ, Logothetis CJ, Hallinan R, et al. Chemotherapy for small cell carcinoma of prostatic origin. J Urol 1992; 147:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/18\">",
"      di Sant'Agnese PA, Cockett AT. Neuroendocrine differentiation in prostatic malignancy. Cancer 1996; 78:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/19\">",
"      di Sant' Agnese PA. Divergent neuroendocrine differentiation in prostatic carcinoma. Semin Diagn Pathol 2000; 17:149.",
"     </a>",
"    </li>",
"    <li>",
"     Prostate. In: American Joint Committee on Cancer Staging Manual, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2009. p.457.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/21\">",
"      Deorah S, Rao MB, Raman R, et al. Survival of patients with small cell carcinoma of the prostate during 1973-2003: a population-based study. BJU Int 2012; 109:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/22\">",
"      T&ecirc;tu B, Ro JY, Ayala AG, et al. Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases. Cancer 1987; 59:1803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/23\">",
"      Bolton DM, Chiu ST, Clarke S, Angus D. Primary small cell carcinoma of the prostate: unusual modes of presentation. Aust N Z J Surg 1994; 64:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/24\">",
"      Steineck G, Reuter V, Kelly WK, et al. Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements. Acta Oncol 2002; 41:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/25\">",
"      Papandreou CN, Daliani DD, Thall PF, et al. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 2002; 20:3072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/26\">",
"      Culine S, El Demery M, Lamy PJ, et al. Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers. J Urol 2007; 178:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/27\">",
"      Aoki H, Ishidoya S, Ito A, et al. Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate. Int J Urol 2006; 13:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/28\">",
"      L&oacute;pez Cubillana P, Mart&iacute;nez Barba E, Prieto A, et al. Oat-cell carcinoma of the prostate. Diagnosis, prognosis and therapeutic implications. Urol Int 2001; 67:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/29\">",
"      Moore SR, Reinberg Y, Zhang G. Small cell carcinoma of prostate: effectiveness of hormonal versus chemotherapy. Urology 1992; 39:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/30\">",
"      Brenner B, Tang LH, Klimstra DS, Kelsen DP. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol 2004; 22:2730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/31\">",
"      Huncharek M, Muscat J. Small cell carcinoma of the esophagus. The Massachusetts General Hospital experience, 1978 to 1993. Chest 1995; 107:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/32\">",
"      Medgyesy CD, Wolff RA, Putnam JB Jr, Ajani JA. Small cell carcinoma of the esophagus: the University of Texas M. D. Anderson Cancer Center experience and literature review. Cancer 2000; 88:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/33\">",
"      Lam KY, Law S, Tung PH, Wong J. Esophageal small cell carcinomas: clinicopathologic parameters, p53 overexpression, proliferation marker, and their impact on pathogenesis. Arch Pathol Lab Med 2000; 124:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/34\">",
"      Pantvaidya GH, Pramesh CS, Deshpande MS, et al. Small cell carcinoma of the esophagus: the Tata Memorial Hospital experience. Ann Thorac Surg 2002; 74:1924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/35\">",
"      Reyes CV, Chejfec G, Jao W, Gould VE. Neuroendocrine carcinomas of the esophagus. Ultrastruct Pathol 1980; 1:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/36\">",
"      Ku GY, Minsky BD, Rusch VW, et al. Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. Ann Oncol 2008; 19:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/37\">",
"      Lv J, Liang J, Wang J, et al. Primary small cell carcinoma of the esophagus. J Thorac Oncol 2008; 3:1460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/38\">",
"      Casas F, Ferrer F, Farr&uacute;s B, et al. Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. Cancer 1997; 80:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/39\">",
"      Briggs JC, Ibrahim NB. Oat cell carcinomas of the oesophagus: a clinico-pathological study of 23 cases. Histopathology 1983; 7:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/40\">",
"      Doherty MA, McIntyre M, Arnott SJ. Oat cell carcinoma of esophagus: a report of six British patients with a review of the literature. Int J Radiat Oncol Biol Phys 1984; 10:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/41\">",
"      Law SY, Fok M, Lam KY, et al. Small cell carcinoma of the esophagus. Cancer 1994; 73:2894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/42\">",
"      Ho KJ, Herrera GA, Jones JM, Alexander CB. Small cell carcinoma of the esophagus: evidence for a unified histogenesis. Hum Pathol 1984; 15:460.",
"     </a>",
"    </li>",
"    <li>",
"     Esophagus and esophagogastic junction. In: American Joint Committee on Cancer Staging Manual, Edge SB, Byrd DR, Compton CC, et al (Eds), S, New York 2009. p.103.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/44\">",
"      Jatoi A, Miller RC. Should we recommend surgery to patients with limited small cell carcinoma of the esophagus? J Thorac Oncol 2008; 3:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/45\">",
"      Huang J, Zhou Y, Zhao X, et al. Primary small cell carcinoma of the stomach: an experience of two decades (1990-2011) in a Chinese cancer institute. J Surg Oncol 2012; 106:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/46\">",
"      Arai K, Matsuda M. Gastric small-cell carcinoma in Japan: a case report and review of the literature. Am J Clin Oncol 1998; 21:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/47\">",
"      Matsui K, Jin XM, Kitagawa M, Miwa A. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Arch Pathol Lab Med 1998; 122:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/48\">",
"      Tanemura H, Ohshita H, Kanno A, et al. A patient with small-cell carcinoma of the stomach with long survival after percutaneous microwave coagulating therapy (PMCT) for liver metastasis. Int J Clin Oncol 2002; 7:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/49\">",
"      Matsui K, Kitagawa M, Miwa A, et al. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Am J Gastroenterol 1991; 86:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/50\">",
"      Takaku H, Oka K, Naoi Y, et al. Primary advanced gastric small cell carcinoma: a case report and review of the literature. Am J Gastroenterol 1999; 94:1402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/51\">",
"      Matsui T, Kataoka M, Sugita Y, et al. A case of small cell carcinoma of the stomach. Hepatogastroenterology 1997; 44:156.",
"     </a>",
"    </li>",
"    <li>",
"     Stomach. In: American Joint Committee on Cancer Staging Manual, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2009. p.103.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/53\">",
"      Burke AB, Shekitka KM, Sobin LH. Small cell carcinomas of the large intestine. Am J Clin Pathol 1991; 95:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/54\">",
"      Yaziji H, Broghamer WL Jr. Primary small cell undifferentiated carcinoma of the rectum associated with ulcerative colitis. South Med J 1996; 89:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/55\">",
"      Schwartz AM, Orenstein JM. Small-cell undifferentiated carcinoma of the rectosigmoid colon. Arch Pathol Lab Med 1985; 109:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/56\">",
"      Read EJ, Orenstein JM, Chorba TL, et al. Listeria monocytogenes sepsis and small cell carcinoma of the rectum: an unusual presentation of the acquired immunodeficiency syndrome. Am J Clin Pathol 1985; 83:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/57\">",
"      Yeg&uuml;ez JF, Martinez SA, Sands DR, et al. Colorectal malignancies in HIV-positive patients. Am Surg 2003; 69:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/58\">",
"      CLERY AP, DOCKERTY MB, WAUGH JM. Small-cell carcinoma of the colon and rectum. A clinicopathologic study. Arch Surg 1961; 83:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/59\">",
"      Shirouzu K, Morodomi T, Isomoto H, et al. Small-cell carcinoma of the rectum. Clinicopathologic study. Dis Colon Rectum 1985; 28:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/60\">",
"      Hung SS. Small cell carcinoma of the colon. A case report and literature review. J Clin Gastroenterol 1989; 11:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/61\">",
"      Sidhu GS. The endodermal origin of digestive and respiratory tract APUD cells. Histopathologic evidence and a review of the literature. Am J Pathol 1979; 96:5.",
"     </a>",
"    </li>",
"    <li>",
"     Colon and rectum. In: American Joint Committee on Cancer Staging Manual, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2009. p.143.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/63\">",
"      Izuishi K, Arai T, Ochiai A, et al. Long-term survival in advanced small cell carcinoma of the colorectum: report of a case. Surg Today 2002; 32:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/64\">",
"      Albores-Saavedra J, Soriano J, Larraza-Hernandez O, et al. Oat cell carcinoma of the gallbladder. Hum Pathol 1984; 15:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/65\">",
"      Fujii H, Aotake T, Horiuchi T, et al. Small cell carcinoma of the gallbladder: a case report and review of 53 cases in the literature. Hepatogastroenterology 2001; 48:1588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/66\">",
"      Maitra A, Tascilar M, Hruban RH, et al. Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases. Am J Surg Pathol 2001; 25:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/67\">",
"      Moskal TL, Zhang PJ, Nava HR. Small cell carcinoma of the gallbladder. J Surg Oncol 1999; 70:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/68\">",
"      Albores-Saavedra J, Cruz-Ortiz H, Alcantara-Vazques A, Henson DE. Unusual types of gallbladder carcinoma. A report of 16 cases. Arch Pathol Lab Med 1981; 105:287.",
"     </a>",
"    </li>",
"    <li>",
"     Gallbladder. In: American Joint Committee on Cancer Staging Manual, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2009. p.211.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/70\">",
"      Matsuo S, Shinozaki T, Yamaguchi S, et al. Small-cell carcinoma of the gallbladder: report of a case. Surg Today 2000; 30:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/71\">",
"      Ferlito A. Diagnosis and treatment of small cell carcinoma of the larynx: a critical review. Ann Otol Rhinol Laryngol 1986; 95:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/72\">",
"      Gnepp DR, Ferlito A, Hyams V. Primary anaplastic small cell (oat cell) carcinoma of the larynx. Review of the literature and report of 18 cases. Cancer 1983; 51:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/73\">",
"      Ferlito A, Barnes L, Rinaldo A, et al. A review of neuroendocrine neoplasms of the larynx: update on diagnosis and treatment. J Laryngol Otol 1998; 112:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/74\">",
"      Mills SE, Cooper PH, Garland TA, Johns ME. Small cell undifferentiated carcinoma of the larynx. Report of two patients and review of 13 additional cases. Cancer 1983; 51:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/75\">",
"      Gianoli GJ, Butcher RB, Martin EJ 3rd. Composite tumor of the larynx. Ear Nose Throat J 1992; 71:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/76\">",
"      Pardo Mind&aacute;n FJ, Algarra SM, Lozano BR, Tapia RG. Oat cell carcinoma of the larynx. A study of six new cases. Histopathology 1989; 14:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/77\">",
"      Ferlito A. Double primary synchronous and metachronous cancer of the larynx and hypopharynx with dissimilar histology. Five case reports and review of the literature. Arch Otorhinolaryngol 1980; 229:107.",
"     </a>",
"    </li>",
"    <li>",
"     Larynx. In: American Joint Committee on Cancer Staging Manual, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2009. p.57.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/79\">",
"      Baugh RF, Wolf GT, Beals TF, et al. Small cell carcinoma of the larynx: results of therapy. Laryngoscope 1986; 96:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/80\">",
"      Giddings NA, Kennedy TL, Vrabec DP. Primary small cell carcinoma of the larynx: analysis of treatment. J Otolaryngol 1987; 16:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/81\">",
"      Aguilar EA 3rd, Robbins KT, Stephens J, et al. Primary oat cell carcinoma of the larynx. Am J Clin Oncol 1987; 10:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/82\">",
"      Nagao K, Matsuzaki O, Saiga H, et al. Histopathologic studies of undifferentiated carcinoma of the parotid gland. Cancer 1982; 50:1572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/83\">",
"      Kraemer BB, Mackay B, Batsakis JG. Small cell carcinomas of the parotid gland. A clinicopathologic study of three cases. Cancer 1983; 52:2115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/84\">",
"      Gnepp DR, Wick MR. Small cell carcinoma of the major salivary glands. An immunohistochemical study. Cancer 1990; 66:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/31/3578/abstract/85\">",
"      Hui KK, Luna MA, Batsakis JG, et al. Undifferentiated carcinomas of the major salivary glands. Oral Surg Oral Med Oral Pathol 1990; 69:76.",
"     </a>",
"    </li>",
"    <li>",
"     Salivary gland. In: American Joint Committee on Cancer Staging Manual, Edge SB, Byrd DR, Compton CC, et al (Eds), Spring, New York 2009. p.79.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4882 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-95F309B6B5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3578=[""].join("\n");
var outline_f3_31_3578=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW OF ESCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Staging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      BLADDER ESCC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PROSTATE ESCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ESOPHAGEAL ESCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      GASTRIC ESCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      COLORECTAL ESCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      GALLBLADDER ESCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      LARYNGEAL ESCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SALIVARY GLAND ESCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/4882\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4882|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/19/41277\" title=\"table 1A\">",
"      TNM staging prostate CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/43/10941\" title=\"table 1B\">",
"      TNM group prostate CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/38/13934\" title=\"table 2\">",
"      TNM staging esoph SCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/6/11374\" title=\"table 3\">",
"      2010 TNM staging stomach CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/26/23982\" title=\"table 4\">",
"      2010 TNM staging colorectal CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/41/6813\" title=\"table 5\">",
"      TNM staging gallbladder CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/14/22766\" title=\"table 6\">",
"      TNM stage larynx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/52/35661\" title=\"table 7\">",
"      TNM stage salivary glands",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9914?source=related_link\">",
"      Chemoradiotherapy for the initial treatment of limited stage small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6712?source=related_link\">",
"      Clinical features and diagnosis of Merkel cell (neuroendocrine) carcinoma and sebaceous cell carcinoma of the skin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11850?source=related_link\">",
"      Clinical features, diagnosis, and staging of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36101?source=related_link\">",
"      Clinical presentation and diagnosis of prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/6/20583?source=related_link\">",
"      Epidemiology and risk factors for head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/35/4661?source=related_link\">",
"      Epidemiology of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32250?source=related_link\">",
"      Epidemiology, pathobiology, and clinical manifestations of esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=related_link\">",
"      First-line chemotherapy for patients with extensive stage small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=related_link\">",
"      Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=related_link\">",
"      Initial hormone therapy for metastatic prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/52/24394?source=related_link\">",
"      Interpretation of prostate biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41174?source=related_link\">",
"      Neuroendocrine cancer of unknown primary site",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/43/36537?source=related_link\">",
"      Overview of the diagnosis and staging of head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=related_link\">",
"      Overview of the risk factors, pathology, and clinical manifestations of lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/53/27481?source=related_link\">",
"      Pathology of bladder neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=related_link\">",
"      Pathology of lung malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=related_link\">",
"      Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11366?source=related_link\">",
"      Small cell carcinoma of the bladder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5498?source=related_link\">",
"      Small cell neuroendocrine carcinoma of the cervix",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/45/41689?source=related_link\">",
"      Treatment of locoregionally advanced (stage III and IV) head and neck cancer: The larynx and hypopharynx",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_31_3579="Duration of pneumonia findings";
var content_f3_31_3579=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F74599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F74599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Usual duration of findings in treated community-acquired pneumonia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Abnormality",
"       </td>",
"       <td class=\"subtitle1\">",
"        Duration (days)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fever",
"       </td>",
"       <td>",
"        2 to 4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cough",
"       </td>",
"       <td>",
"        4 to 9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Crackles",
"       </td>",
"       <td>",
"        3 to 6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leukocytosis",
"       </td>",
"       <td>",
"        3 to 4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C-reactive protein elevation",
"       </td>",
"       <td>",
"        1 to 3",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3579=[""].join("\n");
var outline_f3_31_3579=null;
var title_f3_31_3580="Guidelines after polypectomy II";
var content_f3_31_3580=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Additional surveillance considerations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        1. The present recommendations assume that colonoscopy is complete to the cecum and that bowel preparation is adequate; a repeat examination should be performed if the bowel preparation is not adequate before planning a long-term surveillance program",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. There is clear evidence that the quality of examinations is highly variable; continuous quality improvement process is critical to the effective application of colonoscopy in colorectal cancer prevention",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. A repeat examination is warranted if there is a concern that the polyp was removed incompletely, particularly if it shows high grade dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Endoscopists should make clear recommendations to primary care physicians about when the next colonoscopy is indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Given the evolving nature of guidelines, it is important that physicians and patients should remain in contact so that surveillance recommendations reflect changes in guidelines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. Pending further investigation, performance of FOBT is discouraged in patients undergoing colonoscopic surveillance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7. Discontinuation of surveillance colonoscopy should be considered in patients with serious comorbidities with less than 10 years of life expectancy, according to the clinician's judgment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8. Surveillance guidelines are intended for asymptomatic people; new symptoms may need diagnostic work-up",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9. The application of evolving technologies such as chromoendoscopy, magnification endoscopy, narrow band imaging, and computed tomography colonography are not established for postpolypectomy surveillance at this time",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006; 130:1872. Copyright &copy; 2006 American Gastroenterological Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3580=[""].join("\n");
var outline_f3_31_3580=null;
var title_f3_31_3581="Risk factors for CVT";
var content_f3_31_3581=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F65303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F65303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Systemic and local conditions increasing the risk of cerebral venous thrombosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Transient risk factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Central nervous system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ear, sinus, mouth, face, and neck",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Systemic infectious disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Pregnancy and puerperium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Other disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dehydration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Mechanical precipitants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Head injury",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lumbar puncture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Neurosurgical procedures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Jugular catheter occlusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Oral contraceptives",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hormone replacement therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Androgens",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Asparaginase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tamoxifen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Glucocorticoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Permanent risk factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Inflammatory diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Systemic lupus erythematosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Beh&ccedil;et disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Granulomatosis with polyangiitis (Wegener's)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <span style=\"line-height: 115%; font-family: calibri,sans-serif; font-size: 11pt;\">",
"         Thromboangiitis",
"        </span>",
"        obliterans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Inflammatory bowel disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sarcoidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Malignancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Central nervous system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Solid tumour outside central nervous system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hematologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Hematologic condition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prothrombotic states, genetic or acquired",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Polycythemia, thrombocythemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anemia, including paroxysmal nocturnal hemoglobinuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Central nervous system disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dural fistulae",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Other disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Congenital heart disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Thyroid disease",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3581=[""].join("\n");
var outline_f3_31_3581=null;
var title_f3_31_3582="Water shifts in hemodialysis";
var content_f3_31_3582=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F53752&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F53752&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 517px\">",
"   <div class=\"ttl\">",
"    Water movement during standard hemodialysis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 497px; height: 202px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of water movement during standard hemodialysis. Plasma at an osmolality of 320 mosmol/kg flows into the dialyzer (step 1) which is perfused with a dialysate having an osmolality of 280 mosmol/kg. Diffusive loss of urea (and other small solutes) lowers the osmolality of the fluid returning to the patient (step 2). The ensuing fall in extracellular osmolality creates an osmotic gradient favoring water movement into the cells. This effect plus water loss by ultrafiltration across the dialyzer leads to extracellular volume depletion and may cause hypotension. The rapid fall in plasma osmolality also may play a contributory role, perhaps by interfering with sympathetic responsiveness to volume depletion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3582=[""].join("\n");
var outline_f3_31_3582=null;
var title_f3_31_3583="Starlings forces diff organs";
var content_f3_31_3583=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F59422&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F59422&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Starling's forces in different organs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 388px; height: 178px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Approximate values for Starling's forces in skeletal muscle, lung, and glomeruli. Units are mmHg. The mean capillary oncotic pressure rises in the glomerulus because of the filtration of relatively protein-free fluid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Guyton AC. Textbook of Medical Physiology, 8th ed, Saunders, Philadelphia, 1991, chap 16, and Taylor AE, Circ Res 1981; 49:557.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_31_3583=[""].join("\n");
var outline_f3_31_3583=null;
